| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH8 IQGAP2 MYO5A IPP IMPACT DBN1 IQGAP1 SYNE2 SCNN1A PLEC DMD CAP2 MICAL1 EPS8L2 AKAP5 SYNE1 ENC1 FHOD1 MYH15 MYO15A | 1.03e-08 | 479 | 195 | 21 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR MYH1 MYH8 IQGAP2 MYO5A IPP IMPACT DBN1 MAPK8IP3 IQGAP1 BICD1 SYNE2 SCNN1A FES KIF5C PLEC DMD CAP2 BICD2 MICAL1 EPS8L2 AKAP5 ANK1 SYNM SYNE1 KIF21A CEP290 ENC1 FHOD1 MYH15 MYO15A | 9.48e-08 | 1099 | 195 | 31 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH8 IQGAP2 MYO5A DBN1 IQGAP1 PLEC MICAL1 EPS8L2 SYNE1 FHOD1 MYH15 MYO15A | 3.82e-07 | 227 | 195 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity | 9.17e-07 | 3 | 195 | 3 | GO:0048101 | |
| GeneOntologyMolecularFunction | calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity | 9.17e-07 | 3 | 195 | 3 | GO:0004117 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.40e-06 | 118 | 195 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 PDE1A PDE1C MYH8 PDE1B IQGAP2 MYO5A DAPK2 IQGAP1 AKAP5 MYH15 MYO15A | 2.87e-06 | 230 | 195 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 5.35e-06 | 130 | 195 | 9 | GO:0005200 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.26e-05 | 38 | 195 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 5.62e-05 | 22 | 195 | 4 | GO:0004115 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 6.01e-05 | 43 | 195 | 5 | GO:0008307 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 6.01e-05 | 43 | 195 | 5 | GO:0030280 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 8.04e-05 | 24 | 195 | 4 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 9.50e-05 | 25 | 195 | 4 | GO:0004114 | |
| GeneOntologyMolecularFunction | guanylate cyclase activity | 1.05e-04 | 10 | 195 | 3 | GO:0004383 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP5PF MYH1 ATP6V1B2 MYH8 MYO5A ATP6V1D KIF5C DNAH3 EP400 KIF21A SAE1 RNF213 MSH6 GET3 DNAH17 MYH15 MYO15A | 1.16e-04 | 614 | 195 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 1.30e-04 | 27 | 195 | 4 | GO:0004112 | |
| GeneOntologyMolecularFunction | structural molecule activity | KRT72 TPR MYH8 SPARC NUP62CL BICD1 KRT71 KRT77 PLEC DMD KRT1 KRT3 ANK1 DSP SYNM TNC KRT35 NUP98 PPL MMRN2 MYOM2 | 1.76e-04 | 891 | 195 | 21 | GO:0005198 |
| GeneOntologyMolecularFunction | protein kinase binding | TPR PDE3B MYO5A LYST MAPK8IP3 IQGAP1 BICD1 SYNGAP1 PTPN2 FBXO5 FAM83F TELO2 LRRC7 MICAL1 AKAP5 DSP RICTOR SRCIN1 ELMO2 ACP4 | 3.63e-04 | 873 | 195 | 20 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase binding | TPR PDE3B MYO5A LYST MAPK8IP3 IQGAP1 BICD1 SYNGAP1 PTPN2 FBXO5 FAM83F TELO2 LRRC7 MICAL1 AKAP5 DSP RICTOR SRCIN1 ELMO2 ACP4 MYOM2 | 5.36e-04 | 969 | 195 | 21 | GO:0019900 |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 6.72e-04 | 18 | 195 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 9.31e-04 | 5 | 195 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | cyclase activity | 1.60e-03 | 24 | 195 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 1.60e-03 | 24 | 195 | 3 | GO:0008093 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.80e-03 | 25 | 195 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 1.80e-03 | 25 | 195 | 3 | GO:0016849 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | TRPC4 DBN1 ITGB6 IQGAP1 PTPN2 ADAM17 PLEC DMD EPS8L2 AKAP5 DSP TNC PPL LRRFIP1 | 2.33e-03 | 599 | 195 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | dynein complex binding | 2.51e-03 | 28 | 195 | 3 | GO:0070840 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.51e-03 | 28 | 195 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 2.94e-08 | 99 | 192 | 10 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 3.24e-08 | 100 | 192 | 10 | GO:0045103 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT72 IQGAP2 MYO5A USP9X DBN1 IQGAP1 CEP120 FBXO5 KRT71 KRT77 FES PLEC CAP2 KRT1 KRT3 MICAL1 WASHC4 DSP KRT35 ID1 RICTOR ELMO2 FHOD1 TLR2 PRKCI MYOM2 MYO15A | 2.74e-07 | 957 | 192 | 27 | GO:0097435 |
| GeneOntologyBiologicalProcess | intermediate filament organization | 4.82e-07 | 75 | 192 | 8 | GO:0045109 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 3.15e-06 | 4 | 192 | 3 | GO:2000689 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.15e-05 | 189 | 192 | 10 | GO:0030216 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | SPOCK1 PLXND1 DBN1 IQGAP1 SYNGAP1 ODF2L CEP120 SYNE2 FES LRRC7 ADAM17 DMD EPS8L2 RAP1GAP AKAP5 SYNE1 FAT3 ENC1 ID1 SRCIN1 PRKCI ACP4 | 1.38e-05 | 846 | 192 | 22 | GO:0120035 |
| GeneOntologyBiologicalProcess | keratinization | 1.69e-05 | 87 | 192 | 7 | GO:0031424 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | SPOCK1 PLXND1 DBN1 IQGAP1 SYNGAP1 ODF2L CEP120 SYNE2 FES LRRC7 ADAM17 DMD EPS8L2 RAP1GAP AKAP5 SYNE1 FAT3 ENC1 ID1 SRCIN1 PRKCI ACP4 | 1.88e-05 | 863 | 192 | 22 | GO:0031344 |
| GeneOntologyBiologicalProcess | intracellular transport | TPR DENND2A MYO5A NUP62CL USP9X ARL11 PEX12 DBN1 YJEFN3 LYST RTN2 MAPK8IP3 BICD1 CEP120 SYNE2 AP1G2 LRRC7 KIF5C BICD2 DNAJC13 AKAP5 WASHC4 ANK1 SYNE1 CEP290 NUP98 TXNIP ARFRP1 LMAN1 FHOD1 AP4M1 | 2.15e-05 | 1496 | 192 | 31 | GO:0046907 |
| GeneOntologyBiologicalProcess | cGMP metabolic process | 2.53e-05 | 19 | 192 | 4 | GO:0046068 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SPARC USP9X IMPACT PLXND1 DBN1 F2 ITGB6 MAPK8IP3 IQGAP1 SYNGAP1 FES AHR ADAM17 FGFR2 KIF5C PLEC DMD CAP2 AKAP5 SYNE1 FAT3 ID1 FRYL SRCIN1 SIDT2 PLEKHO1 | 4.75e-05 | 1194 | 192 | 26 | GO:0000902 |
| GeneOntologyBiologicalProcess | skin development | KRT72 MYO5A ITGB6 KRT71 KRT77 KAZN FGFR2 PLEC KRT1 KRT3 DSP PPL TXNIP | 4.98e-05 | 373 | 192 | 13 | GO:0043588 |
| GeneOntologyBiologicalProcess | nucleus localization | 5.37e-05 | 44 | 192 | 5 | GO:0051647 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | SPOCK1 PLXND1 DBN1 IQGAP1 SYNGAP1 FES LRRC7 ADAM17 DMD AKAP5 SYNE1 FAT3 ENC1 ID1 SRCIN1 PRKCI ACP4 | 6.21e-05 | 612 | 192 | 17 | GO:0010975 |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly | 6.40e-05 | 9 | 192 | 3 | GO:0000915 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in cytokinesis | 6.40e-05 | 9 | 192 | 3 | GO:0000912 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | TPR MYO5A NUP62CL USP9X ARL11 PEX12 YJEFN3 RTN2 MAPK8IP3 AP1G2 LRRC7 KIF5C AKAP5 CEP290 NUP98 TXNIP ARFRP1 LMAN1 AP4M1 | 6.53e-05 | 740 | 192 | 19 | GO:0006886 |
| GeneOntologyBiologicalProcess | cAMP-mediated signaling | 7.66e-05 | 76 | 192 | 6 | GO:0019933 | |
| GeneOntologyBiologicalProcess | actin filament organization | IQGAP2 MYO5A DBN1 IQGAP1 PLEC CAP2 MICAL1 WASHC4 ID1 RICTOR ELMO2 FHOD1 TLR2 PRKCI MYO15A | 8.87e-05 | 509 | 192 | 15 | GO:0007015 |
| GeneOntologyBiologicalProcess | actomyosin contractile ring organization | 9.08e-05 | 10 | 192 | 3 | GO:0044837 | |
| GeneOntologyBiologicalProcess | axo-dendritic protein transport | 1.24e-04 | 11 | 192 | 3 | GO:0099640 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH8 IQGAP2 MYO5A DBN1 IQGAP1 SYNE2 PLEC CAP2 MICAL1 WASHC4 DSP ID1 RICTOR SRCIN1 ELMO2 FHOD1 TLR2 TBCK PRKCI MYOM2 MYO15A | 1.25e-04 | 912 | 192 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | neuron projection development | SPOCK1 USP9X IMPACT PLXND1 DBN1 MAPK8IP3 IQGAP1 SYNGAP1 FES LRRC7 ADAM17 FGFR2 KIF5C DMD HERC1 CUL4B AKAP5 TNC SYNE1 FAT3 ENC1 ID1 FRYL SRCIN1 PRKCI ACP4 | 1.57e-04 | 1285 | 192 | 26 | GO:0031175 |
| GeneOntologyBiologicalProcess | cGMP biosynthetic process | 1.64e-04 | 12 | 192 | 3 | GO:0006182 | |
| GeneOntologyBiologicalProcess | cellular response to macrophage colony-stimulating factor stimulus | 2.12e-04 | 13 | 192 | 3 | GO:0036006 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | KNTC1 TPR NUP62CL USP9X PEX12 YJEFN3 F2 BICD1 ATP6V1D AHR CC2D2A LRRC7 BICD2 AKAP5 SYNE1 NUP98 SAE1 TXNIP ARFRP1 LMAN1 GET3 AP4M1 CFAP53 | 2.15e-04 | 1091 | 192 | 23 | GO:0033365 |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 2.57e-04 | 3 | 192 | 2 | GO:1902407 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 2.57e-04 | 3 | 192 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 2.57e-04 | 3 | 192 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | nuclear migration | 2.71e-04 | 34 | 192 | 4 | GO:0007097 | |
| GeneOntologyBiologicalProcess | response to radiation | ERCC4 RNF168 PDE1B RRM1 ITGB6 SYNGAP1 CUL4B TICRR SYNE1 MSH6 MTA1 GUCY2F PAXIP1 MYO15A | 2.74e-04 | 503 | 192 | 14 | GO:0009314 |
| GeneOntologyBiologicalProcess | centrosome localization | 3.04e-04 | 35 | 192 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 3.40e-04 | 36 | 192 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 3.43e-04 | 284 | 192 | 10 | GO:0009913 | |
| GeneOntologyBiologicalProcess | microtubule-based protein transport | 4.90e-04 | 17 | 192 | 3 | GO:0099118 | |
| GeneOntologyBiologicalProcess | protein transport along microtubule | 4.90e-04 | 17 | 192 | 3 | GO:0098840 | |
| GeneOntologyBiologicalProcess | response to macrophage colony-stimulating factor | 4.90e-04 | 17 | 192 | 3 | GO:0036005 | |
| GeneOntologyBiologicalProcess | neuron development | SPOCK1 USP9X IMPACT PLXND1 DBN1 MAPK8IP3 IQGAP1 SYNGAP1 FES LRRC7 ADAM17 FGFR2 KIF5C DMD HERC1 CUL4B AKAP5 TNC SYNE1 FAT3 CEP290 ENC1 ID1 FRYL SRCIN1 PRKCI ACP4 | 5.02e-04 | 1463 | 192 | 27 | GO:0048666 |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 5.11e-04 | 4 | 192 | 2 | GO:0043578 | |
| GeneOntologyBiologicalProcess | minus-end-directed organelle transport along microtubule | 5.11e-04 | 4 | 192 | 2 | GO:0072385 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | IQGAP2 MYO5A DBN1 IQGAP1 PLEC CAP2 MICAL1 WASHC4 ID1 RICTOR SRCIN1 ELMO2 FHOD1 TLR2 TBCK PRKCI MYOM2 MYO15A | 5.30e-04 | 803 | 192 | 18 | GO:0030036 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT72 KNTC1 MYH1 MYH8 IQGAP2 MYO5A LRRC49 STYXL2 GCK DBN1 RTN2 IQGAP1 BICD1 KRT71 KRT77 SYNE2 KIF5C PLEC DMD KRT1 KRT3 MICAL1 DNAH3 ANK1 DSP SYNM KRT35 SYNE1 KIF21A PPL MTA1 LMAN1 DNAH17 MYH15 MYOM2 CFAP53 | 3.03e-10 | 1179 | 196 | 36 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT72 KNTC1 MYH1 MYH8 IQGAP2 MYO5A LRRC49 STYXL2 GCK DBN1 RTN2 IQGAP1 BICD1 KRT71 KRT77 SYNE2 KIF5C PLEC DMD KRT1 KRT3 MICAL1 DNAH3 ANK1 DSP SYNM KRT35 SYNE1 KIF21A PPL MTA1 LMAN1 DNAH17 MYH15 MYOM2 CFAP53 | 3.65e-10 | 1187 | 196 | 36 | GO:0099081 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT72 MYO5A RTN2 KRT71 KRT77 SYNE2 PLEC DMD KRT1 KRT3 MICAL1 DSP SYNM KRT35 PPL | 2.95e-08 | 263 | 196 | 15 | GO:0045111 |
| GeneOntologyCellularComponent | intermediate filament | KRT72 MYO5A RTN2 KRT71 KRT77 PLEC DMD KRT1 KRT3 MICAL1 DSP SYNM KRT35 PPL | 3.27e-08 | 227 | 196 | 14 | GO:0005882 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT72 KNTC1 IQGAP2 MYO5A LRRC49 GCK DBN1 RTN2 IQGAP1 BICD1 KRT71 KRT77 KIF5C PLEC DMD KRT1 KRT3 MICAL1 DNAH3 DSP SYNM KRT35 KIF21A PPL MTA1 DNAH17 CFAP53 | 9.27e-08 | 899 | 196 | 27 | GO:0099513 |
| GeneOntologyCellularComponent | actin cytoskeleton | KNTC1 MYH1 DENND2A MYH8 IQGAP2 MYO5A RGS22 IPP GCK DBN1 IQGAP1 SCNN1A LRRC7 ADAM17 MICAL1 ANKRD26 SRCIN1 FHOD1 CORIN MYH15 MYO15A | 1.22e-07 | 576 | 196 | 21 | GO:0015629 |
| GeneOntologyCellularComponent | cell leading edge | ATP6V1B2 IQGAP2 MYO5A MCC PLXND1 DBN1 MAPK8IP3 IQGAP1 SYNE2 ADAM17 DMD SHISA6 EPS8L2 AKAP5 ANK1 SRCIN1 PRKCI PLEKHO1 | 1.22e-06 | 500 | 196 | 18 | GO:0031252 |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH8 STYXL2 RTN2 SYNE2 PLEC DMD ANK1 SYNM SYNE1 LMAN1 MYH15 MYOM2 | 1.95e-06 | 273 | 196 | 13 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH8 STYXL2 RTN2 SYNE2 PLEC DMD ANK1 SYNM SYNE1 LMAN1 MYH15 MYOM2 | 3.78e-06 | 290 | 196 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | MYH1 MYH8 STYXL2 RTN2 SYNE2 PLEC DMD ANK1 SYNM SYNE1 LMAN1 MYOM2 | 4.31e-06 | 249 | 196 | 12 | GO:0030017 |
| GeneOntologyCellularComponent | filopodium | 2.12e-05 | 123 | 196 | 8 | GO:0030175 | |
| GeneOntologyCellularComponent | actin-based cell projection | ATP6V1B2 IQGAP2 MYO5A DBN1 SYNE2 LRRC7 DMD EPS8L2 AKAP5 SRCIN1 MYO15A | 6.65e-05 | 278 | 196 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | myosin filament | 8.13e-05 | 25 | 196 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | leading edge membrane | PLXND1 MAPK8IP3 SYNE2 ADAM17 SHISA6 EPS8L2 AKAP5 ANK1 PLEKHO1 | 1.70e-04 | 210 | 196 | 9 | GO:0031256 |
| GeneOntologyCellularComponent | cell cortex | IQGAP2 TRPC4 GCK DBN1 MELK IQGAP1 SCNN1A EXOC3L1 FGFR2 ANK1 FRYL GUCY1B1 | 2.09e-04 | 371 | 196 | 12 | GO:0005938 |
| GeneOntologyCellularComponent | myosin complex | 2.29e-04 | 59 | 196 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | TTT Hsp90 cochaperone complex | 2.61e-04 | 3 | 196 | 2 | GO:0110078 | |
| GeneOntologyCellularComponent | cornified envelope | 4.76e-04 | 69 | 196 | 5 | GO:0001533 | |
| GeneOntologyCellularComponent | somatodendritic compartment | PDE1A PDE1C PDE1B MYO5A ADAM21 DBN1 RRM1 MAPK8IP3 SYNGAP1 LRRC7 GNAI2 KIF5C PLEC DMD SHISA6 RAP1GAP AKAP5 SYNE1 FAT3 KIF21A ENC1 GRIK4 SRCIN1 PPP2R1A | 5.27e-04 | 1228 | 196 | 24 | GO:0036477 |
| GeneOntologyCellularComponent | filopodium membrane | 9.53e-04 | 21 | 196 | 3 | GO:0031527 | |
| GeneOntologyCellularComponent | costamere | 1.10e-03 | 22 | 196 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | cell body | PDE1A PDE1C PDE1B MYO5A ADAM21 PLXND1 DBN1 RRM1 MAPK8IP3 GNAI2 KIF5C DMD RAP1GAP AKAP5 ENC1 GRIK4 SRCIN1 PPP2R1A TLR2 | 1.22e-03 | 929 | 196 | 19 | GO:0044297 |
| GeneOntologyCellularComponent | phosphatase complex | 1.76e-03 | 55 | 196 | 4 | GO:1903293 | |
| GeneOntologyCellularComponent | protein serine/threonine phosphatase complex | 1.76e-03 | 55 | 196 | 4 | GO:0008287 | |
| GeneOntologyCellularComponent | axon | MYO5A SPOCK1 ADAM21 USP9X PLXND1 DBN1 MAPK8IP3 IQGAP1 LRRC7 KIF5C PLEC DMD MICAL1 RAP1GAP ANK1 KIF21A GRIK4 SRCIN1 | 1.87e-03 | 891 | 196 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | anchoring junction | MYH1 TRPC4 DBN1 ITGB6 IQGAP1 SYNE2 FES LRRC7 ADAM17 KAZN PLEC DMD DSP SYNM TNC SRCIN1 PPL FHOD1 PRKCI | 2.13e-03 | 976 | 196 | 19 | GO:0070161 |
| GeneOntologyCellularComponent | keratin filament | 2.21e-03 | 97 | 196 | 5 | GO:0045095 | |
| GeneOntologyCellularComponent | myosin II complex | 2.24e-03 | 28 | 196 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | desmosome | 2.24e-03 | 28 | 196 | 3 | GO:0030057 | |
| GeneOntologyCellularComponent | cell projection membrane | PLXND1 MAPK8IP3 SYNE2 SCNN1A ADAM17 DMD SHISA6 EPS8L2 AKAP5 ANK1 PLEKHO1 | 2.59e-03 | 431 | 196 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | rod photoreceptor outer segment | 3.02e-03 | 9 | 196 | 2 | GO:0120200 | |
| GeneOntologyCellularComponent | TORC2 complex | 3.02e-03 | 9 | 196 | 2 | GO:0031932 | |
| GeneOntologyCellularComponent | RNA polymerase III transcription regulator complex | 3.02e-03 | 9 | 196 | 2 | GO:0090576 | |
| GeneOntologyCellularComponent | dendrite | MYO5A DBN1 MAPK8IP3 SYNGAP1 LRRC7 GNAI2 KIF5C PLEC SHISA6 RAP1GAP AKAP5 SYNE1 FAT3 KIF21A GRIK4 SRCIN1 PPP2R1A | 3.04e-03 | 858 | 196 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | Z disc | 3.05e-03 | 151 | 196 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | dendritic tree | MYO5A DBN1 MAPK8IP3 SYNGAP1 LRRC7 GNAI2 KIF5C PLEC SHISA6 RAP1GAP AKAP5 SYNE1 FAT3 KIF21A GRIK4 SRCIN1 PPP2R1A | 3.12e-03 | 860 | 196 | 17 | GO:0097447 |
| Domain | Spectrin_repeat | 1.62e-08 | 29 | 196 | 7 | IPR002017 | |
| Domain | SPEC | 3.39e-08 | 32 | 196 | 7 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.39e-08 | 32 | 196 | 7 | IPR018159 | |
| Domain | - | USP9X TELO2 AP1G2 DNAJC13 RICTOR FRYL PPP4R4 PPP2R1A PPP2R1B MROH1 ELMO2 FHOD1 TTI1 | 6.61e-07 | 222 | 196 | 13 | 1.25.10.10 |
| Domain | PDEase_N | 1.14e-06 | 3 | 196 | 3 | IPR013706 | |
| Domain | PDEase_I_N | 1.14e-06 | 3 | 196 | 3 | PF08499 | |
| Domain | ARM-type_fold | USP9X LYST TELO2 AP1G2 DNAJC13 RICTOR FRYL PAIP1 PPP4R4 PPP2R1A PPP2R1B MROH1 ELMO2 FHOD1 TTI1 | 3.10e-06 | 339 | 196 | 15 | IPR016024 |
| Domain | Intermediate_filament_CS | 4.24e-06 | 63 | 196 | 7 | IPR018039 | |
| Domain | Keratin_2_head | 4.37e-06 | 24 | 196 | 5 | IPR032444 | |
| Domain | Keratin_2_head | 4.37e-06 | 24 | 196 | 5 | PF16208 | |
| Domain | CH | 5.24e-06 | 65 | 196 | 7 | SM00033 | |
| Domain | ARM-like | USP9X TELO2 AP1G2 DNAJC13 RICTOR FRYL PPP4R4 PPP2R1A PPP2R1B MROH1 ELMO2 FHOD1 TTI1 | 5.79e-06 | 270 | 196 | 13 | IPR011989 |
| Domain | Keratin_II | 6.65e-06 | 26 | 196 | 5 | IPR003054 | |
| Domain | CH | 8.63e-06 | 70 | 196 | 7 | PF00307 | |
| Domain | Filament | 9.49e-06 | 71 | 196 | 7 | SM01391 | |
| Domain | - | 9.49e-06 | 71 | 196 | 7 | 1.10.418.10 | |
| Domain | IF | 1.04e-05 | 72 | 196 | 7 | PS00226 | |
| Domain | RasGAP | 1.08e-05 | 14 | 196 | 4 | SM00323 | |
| Domain | RasGAP_CS | 1.08e-05 | 14 | 196 | 4 | IPR023152 | |
| Domain | CH | 1.14e-05 | 73 | 196 | 7 | PS50021 | |
| Domain | Filament | 1.14e-05 | 73 | 196 | 7 | PF00038 | |
| Domain | CH-domain | 1.37e-05 | 75 | 196 | 7 | IPR001715 | |
| Domain | RasGAP | 1.47e-05 | 15 | 196 | 4 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 1.47e-05 | 15 | 196 | 4 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 1.47e-05 | 15 | 196 | 4 | PS50018 | |
| Domain | IF | 1.49e-05 | 76 | 196 | 7 | IPR001664 | |
| Domain | - | 1.94e-05 | 16 | 196 | 4 | 1.10.506.10 | |
| Domain | HEAT_type_2 | 2.52e-05 | 17 | 196 | 4 | IPR021133 | |
| Domain | RasGAP_dom | 3.21e-05 | 18 | 196 | 4 | IPR001936 | |
| Domain | Plectin | 3.86e-05 | 7 | 196 | 3 | PF00681 | |
| Domain | Plectin_repeat | 3.86e-05 | 7 | 196 | 3 | IPR001101 | |
| Domain | PLEC | 3.86e-05 | 7 | 196 | 3 | SM00250 | |
| Domain | Myosin-like_IQ_dom | 4.03e-05 | 19 | 196 | 4 | IPR027401 | |
| Domain | - | 4.03e-05 | 19 | 196 | 4 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 4.58e-05 | 38 | 196 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.58e-05 | 38 | 196 | 5 | PS51456 | |
| Domain | Myosin_head | 4.58e-05 | 38 | 196 | 5 | PF00063 | |
| Domain | MYSc | 4.58e-05 | 38 | 196 | 5 | SM00242 | |
| Domain | IQ | 5.57e-05 | 93 | 196 | 7 | PS50096 | |
| Domain | PDEase_I | 6.12e-05 | 21 | 196 | 4 | PF00233 | |
| Domain | PDEASE_I | 6.12e-05 | 21 | 196 | 4 | PS00126 | |
| Domain | PDEase_CS | 6.12e-05 | 21 | 196 | 4 | IPR023174 | |
| Domain | - | 7.42e-05 | 22 | 196 | 4 | 1.10.1300.10 | |
| Domain | ACTININ_2 | 8.91e-05 | 23 | 196 | 4 | PS00020 | |
| Domain | ACTININ_1 | 8.91e-05 | 23 | 196 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.91e-05 | 23 | 196 | 4 | IPR001589 | |
| Domain | PDEase_catalytic_dom | 8.91e-05 | 23 | 196 | 4 | IPR002073 | |
| Domain | IQ | 1.01e-04 | 71 | 196 | 6 | PF00612 | |
| Domain | HD/PDEase_dom | 1.06e-04 | 24 | 196 | 4 | IPR003607 | |
| Domain | HDc | 1.06e-04 | 24 | 196 | 4 | SM00471 | |
| Domain | Prefoldin | 1.09e-04 | 72 | 196 | 6 | IPR009053 | |
| Domain | PP2A_A_meta | 1.10e-04 | 2 | 196 | 2 | IPR031090 | |
| Domain | Bicaudal-D_microtubule-assoc | 1.10e-04 | 2 | 196 | 2 | IPR018477 | |
| Domain | BicD | 1.10e-04 | 2 | 196 | 2 | PF09730 | |
| Domain | IQ | 2.09e-04 | 81 | 196 | 6 | SM00015 | |
| Domain | P-loop_NTPase | MYH1 ATP6V1B2 MYH8 MYO5A ARL11 NDST4 CHST6 IQGAP1 GNAI2 KIF5C DNAH3 NWD1 EP400 KIF21A RNF213 MSH6 ARFRP1 GET3 RASEF MYH15 MYO15A | 2.37e-04 | 848 | 196 | 21 | IPR027417 |
| Domain | RasGAP_C | 3.26e-04 | 3 | 196 | 2 | IPR000593 | |
| Domain | RasGAP_C | 3.26e-04 | 3 | 196 | 2 | PF03836 | |
| Domain | IQ_motif_EF-hand-BS | 3.71e-04 | 90 | 196 | 6 | IPR000048 | |
| Domain | Myosin_N | 4.72e-04 | 15 | 196 | 3 | PF02736 | |
| Domain | Myosin_N | 4.72e-04 | 15 | 196 | 3 | IPR004009 | |
| Domain | KASH | 6.48e-04 | 4 | 196 | 2 | IPR012315 | |
| Domain | KASH | 6.48e-04 | 4 | 196 | 2 | PS51049 | |
| Domain | KASH | 6.48e-04 | 4 | 196 | 2 | SM01249 | |
| Domain | KASH | 6.48e-04 | 4 | 196 | 2 | PF10541 | |
| Domain | TF_Zn_Ribbon | 6.48e-04 | 4 | 196 | 2 | PF08271 | |
| Domain | Znf_TFIIB | 6.48e-04 | 4 | 196 | 2 | IPR013137 | |
| Domain | A/G_cyclase_CS | 6.94e-04 | 17 | 196 | 3 | IPR018297 | |
| Domain | Myosin_tail_1 | 8.27e-04 | 18 | 196 | 3 | PF01576 | |
| Domain | Myosin_tail | 8.27e-04 | 18 | 196 | 3 | IPR002928 | |
| Domain | - | 8.27e-04 | 18 | 196 | 3 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 8.27e-04 | 18 | 196 | 3 | IPR029787 | |
| Domain | Guanylate_cyc | 9.74e-04 | 19 | 196 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 9.74e-04 | 19 | 196 | 3 | PS50125 | |
| Domain | PDEase | 9.74e-04 | 19 | 196 | 3 | IPR023088 | |
| Domain | A/G_cyclase | 9.74e-04 | 19 | 196 | 3 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 9.74e-04 | 19 | 196 | 3 | PS00452 | |
| Domain | CYCc | 9.74e-04 | 19 | 196 | 3 | SM00044 | |
| Domain | Keratin_I | 1.15e-03 | 44 | 196 | 4 | IPR002957 | |
| Domain | - | 1.60e-03 | 6 | 196 | 2 | 3.90.1290.10 | |
| Domain | HNOB_dom_associated | 1.60e-03 | 6 | 196 | 2 | IPR011645 | |
| Domain | Myb-like_dom | 1.60e-03 | 6 | 196 | 2 | IPR017877 | |
| Domain | HNOBA | 1.60e-03 | 6 | 196 | 2 | PF07701 | |
| Domain | Spectrin | 1.73e-03 | 23 | 196 | 3 | PF00435 | |
| Domain | Rho_GTPase_activation_prot | 2.34e-03 | 88 | 196 | 5 | IPR008936 | |
| Domain | SPARC/Testican_Ca-bd-dom | 2.94e-03 | 8 | 196 | 2 | IPR019577 | |
| Domain | SPARC_Ca_bdg | 2.94e-03 | 8 | 196 | 2 | PF10591 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 5.49e-06 | 87 | 157 | 8 | MM15351 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.37e-05 | 129 | 157 | 9 | M27649 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 2.64e-05 | 6 | 157 | 3 | MM14494 | |
| Pubmed | KRT72 KNTC1 ATP5PF MYH1 MYH8 IQGAP2 MYO5A SPOCK1 DBN1 LYST IQGAP1 KRT71 KRT77 SYNE2 CC2D2A GNAI2 KIF5C PLEC DMD KRT1 KRT3 AKAP5 DSP SYNE1 KIF21A NUP98 ANKRD26 PPL PPP4R4 GTF3C1 DGKK MYH15 MYOM2 | 1.26e-11 | 1442 | 200 | 33 | 35575683 | |
| Pubmed | ATP6V1B2 MYO5A USP9X PTPN2 TXNDC5 TELO2 SYNE2 DMD HERC1 CAP2 DNAJC13 AKAP5 DSP ST7 CEP290 NUP98 RNF213 RICTOR PPP4R4 MSH6 PPP2R1A GTF2E1 LMAN1 TTI1 PRKCI SETD7 | 4.45e-10 | 1049 | 200 | 26 | 27880917 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TPR USP9X RRM1 IQGAP1 PLEC EP400 SAE1 RNF213 XPNPEP1 MSH6 PPP2R1A MTA1 GTF3C1 TTI1 LAS1L | 1.08e-09 | 332 | 200 | 15 | 32786267 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 ATP6V1B2 USP9X RRM1 TTC1 IQGAP1 TXNDC5 TELO2 GNAI2 PLEC HERC1 ANKRD40 CAP2 CUL4B WASHC4 KIF21A NUP98 SAE1 FRYL XPNPEP1 PAIP1 MSH6 PPP2R1A PPP2R1B GTF2E1 GET3 TTI1 DCAF11 LRRFIP1 | 5.83e-09 | 1455 | 200 | 29 | 22863883 |
| Pubmed | KRT72 DENND2A ATP6V1B2 PDE1C IQGAP2 MYO5A USP9X LRRC49 DBN1 YJEFN3 MAPK8IP3 IQGAP1 SYNGAP1 ATP6V1D LRRC7 KIF5C PLEC DMD KRT1 MICAL1 DNAJC13 RAP1GAP DSP TNC SYNE1 SRCIN1 PPP2R1A LRRFIP1 | 1.63e-08 | 1431 | 200 | 28 | 37142655 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | KNTC1 TPR ATP5PF ATP6V1B2 USP9X MCC RRM1 ATP6V1D LRRC7 KIF5C PLEC CUL4B DNAH3 DSP KIF21A SAE1 MSH6 PPP2R1A MTA1 GET3 LRRFIP1 | 2.36e-08 | 847 | 200 | 21 | 35235311 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | KNTC1 MYO5A IQGAP1 PLEC KRT1 DNAJC13 DSP RICTOR FRYL NBAS MSH6 | 2.88e-08 | 202 | 200 | 11 | 33005030 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PDE3B MYO5A YJEFN3 TTF1 MAPK8IP3 BICD1 ODF2L SCNN1A LRRC7 KIF5C MAML3 CAP2 ENOSF1 PSMF1 DNAJC13 RASA2 ST7 ENC1 RNF213 FRYL SRCIN1 PPP4R4 DNTTIP1 PPP2R1B GTF3C1 TBCK RASEF PRKCI | 3.75e-08 | 1489 | 200 | 28 | 28611215 |
| Pubmed | TPR PDE1B IQGAP2 MYO5A USP9X TRPC4 MCC DBN1 MAPK8IP3 IQGAP1 SYNGAP1 SYNE2 LRRC7 KIF5C CAP2 SIN3B DNAJC13 SYNE1 KIF21A PPP2R1A PRKCI LRRFIP1 | 4.54e-08 | 963 | 200 | 22 | 28671696 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KNTC1 TPR NUP62CL MCC IQGAP1 ODF2L CEP120 FBXO5 GNAI2 HSF2 CUL4B BICD2 NPR1 WASHC4 SYNE1 NUP98 PPL NBAS PPP2R1A PPP2R1B GTF3C1 PRKCI DCAF11 TGS1 | 6.28e-08 | 1155 | 200 | 24 | 20360068 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | IQGAP2 MYO5A USP9X DBN1 IQGAP1 SYNGAP1 PIP5KL1 LRRC7 SHISA6 SYNE1 SRCIN1 PPP2R1A | 9.72e-08 | 281 | 200 | 12 | 28706196 |
| Pubmed | USP9X DBN1 IQGAP1 TXNDC5 KRT77 PLEC DMD KRT1 RAP1GAP DSP TNC KRT35 PPL PPP2R1A PPP2R1B | 1.78e-07 | 488 | 200 | 15 | 31324722 | |
| Pubmed | 1.87e-07 | 3 | 200 | 3 | 9003415 | ||
| Pubmed | 1.87e-07 | 3 | 200 | 3 | 7568196 | ||
| Pubmed | Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes. | 1.87e-07 | 3 | 200 | 3 | 17726023 | |
| Pubmed | 1.87e-07 | 3 | 200 | 3 | 18335582 | ||
| Pubmed | 1.87e-07 | 3 | 200 | 3 | 33472039 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | USP9X RRM1 TTC1 IQGAP1 PTPN2 TXNDC5 SYNE2 GNAI2 SIN3B PSMF1 DNAJC13 DSP KIF21A NUP98 RNF213 FRYL XPNPEP1 PAIP1 PPL MSH6 PPP2R1A PPP2R1B LMAN1 GET3 LRRFIP1 | 3.62e-07 | 1367 | 200 | 25 | 32687490 |
| Pubmed | 3.88e-07 | 159 | 200 | 9 | 30581152 | ||
| Pubmed | ATP6V1B2 MYO5A USP9X MAPK8IP3 IQGAP1 BICD1 SYNGAP1 ODF2L USP32 KIF5C PLEC CAP2 BICD2 RAP1GAP WASHC4 DSP SYNM SYNE1 KIF21A CEP290 ENC1 MTA1 GUCY1B1 LRRFIP1 | 4.36e-07 | 1285 | 200 | 24 | 35914814 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR DBN1 MAPK8IP3 IQGAP1 PLEC CUL4B BICD2 DNAJC13 EP400 DSP NUP98 RICTOR PPL MSH6 MTA1 GTF3C1 FHOD1 LRRFIP1 | 6.30e-07 | 774 | 200 | 18 | 15302935 |
| Pubmed | 7.29e-07 | 13 | 200 | 4 | 8557689 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT72 KNTC1 MYO5A DBN1 KRT77 CC2D2A PLEC KRT1 EP400 DSP KRT35 CEP290 MROH1 FHOD1 MYO15A | 1.10e-06 | 564 | 200 | 15 | 21565611 |
| Pubmed | MYO5A DBN1 SYNGAP1 LRRC7 MICAL1 SRCIN1 TG PPP2R1A ELMO2 LRRFIP1 | 1.11e-06 | 233 | 200 | 10 | 29518331 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 PDE3B AHR LRRC7 KAZN NEMP1 TICRR SIN3B DNAH3 ANK1 DSP KIF21A CEP290 PCDHB14 RNF213 MSH6 GTF3C1 | 1.43e-06 | 736 | 200 | 17 | 29676528 |
| Pubmed | 1.74e-06 | 63 | 200 | 6 | 16831889 | ||
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | TPR PDE3B PTPN2 TXNDC5 SYNE2 KRT1 NEMP1 SIN3B NUP98 NBAS MSH6 LMAN1 | 2.06e-06 | 375 | 200 | 12 | 32788342 |
| Pubmed | 2.09e-06 | 65 | 200 | 6 | 29795372 | ||
| Pubmed | 2.18e-06 | 102 | 200 | 7 | 9734811 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TTC1 IQGAP1 BICD1 ODF2L CEP120 KIF5C PLEC CUL4B BICD2 DSP ST7 CEP290 ANKRD26 PAIP1 ELMO2 CEP41 RASEF AP4M1 | 2.48e-06 | 853 | 200 | 18 | 28718761 |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 2.85e-06 | 202 | 200 | 9 | 33601422 | |
| Pubmed | 3.70e-06 | 6 | 200 | 3 | 18827015 | ||
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 3.82e-06 | 72 | 200 | 6 | 25917818 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT72 TPR MYO5A DBN1 IQGAP1 PTPN2 FAM83F KRT77 GNAI2 PLEC KRT1 KRT3 DSP SYNM NUP98 PPL MSH6 PPP2R1A GTF3C1 FHOD1 LAS1L LRRFIP1 | 3.89e-06 | 1257 | 200 | 22 | 36526897 |
| Pubmed | TPR MYO5A USP9X LRRC49 IQGAP1 POLR1F DSP MSH6 PPP2R1A MTA1 GTF3C1 LRRFIP1 | 3.89e-06 | 399 | 200 | 12 | 37536630 | |
| Pubmed | ATP6V1B2 EED MYO5A IQGAP1 TXNDC5 KRT77 GNAI2 KIF5C PLEC CUL4B KRT1 DNAH3 DNAJC13 DSP SYNE1 SAE1 TG | 4.58e-06 | 803 | 200 | 17 | 36517590 | |
| Pubmed | 4.78e-06 | 20 | 200 | 4 | 21689717 | ||
| Pubmed | 5.88e-06 | 21 | 200 | 4 | 27740716 | ||
| Pubmed | TPR PDE1A DBN1 TTC1 ITGB6 PTPN2 SYNE2 CUL4B BICD2 DSP NUP98 LYSMD3 NBAS LMAN1 | 6.03e-06 | 568 | 200 | 14 | 37774976 | |
| Pubmed | Exons 5-15 of kazrin are dispensable for murine epidermal morphogenesis and homeostasis. | 6.45e-06 | 7 | 200 | 3 | 22513779 | |
| Pubmed | Synemin promotes AKT-dependent glioblastoma cell proliferation by antagonizing PP2A. | 6.45e-06 | 7 | 200 | 3 | 22337773 | |
| Pubmed | TPR MYO5A USP9X TTF1 IQGAP1 SYNE2 PLEC CUL4B DSP NUP98 FRYL MSH6 PPP2R1A GTF3C1 LAS1L | 6.49e-06 | 653 | 200 | 15 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR ATP6V1B2 MYO5A USP9X IQGAP1 TXNDC5 KRT77 SYNE2 GNAI2 PLEC EP400 DSP SYNE1 CEP290 NUP98 PPP2R1A GTF3C1 GET3 LAS1L | 8.18e-06 | 1024 | 200 | 19 | 24711643 |
| Pubmed | 9.36e-06 | 234 | 200 | 9 | 36243803 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | USP9X TTC1 TELO2 AHR AP1G2 DMD BICD2 EPS8L2 RAP1GAP WASHC4 RICTOR TFE3 DNTTIP1 CEP41 PAXIP1 PRKCI AP4M1 LAS1L TGS1 | 9.90e-06 | 1038 | 200 | 19 | 26673895 |
| Pubmed | 1.03e-05 | 8 | 200 | 3 | 20110084 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | SPARC MYO5A DAPK2 DBN1 MELK PTPN2 CC2D2A ADAM17 KAZN HERC1 ENC1 FRYL XPNPEP1 MTA1 CGRRF1 DNAH17 CEP41 DCAF11 AP4M1 MYO15A CFAP53 | 1.10e-05 | 1242 | 200 | 21 | 30973865 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PDE3B DAPK2 MELK LYST POLR1F KRT77 SYNE2 KIF5C PLEC RAP1GAP DSP ANKRD26 RICTOR FRYL PPP4R4 ELMO2 PRKCI | 1.13e-05 | 861 | 200 | 17 | 36931259 |
| Pubmed | 1.14e-05 | 131 | 200 | 7 | 28634551 | ||
| Pubmed | 1.15e-05 | 87 | 200 | 6 | 12465718 | ||
| Pubmed | 1.22e-05 | 25 | 200 | 4 | 17307970 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR MYO5A RRM1 MELK IQGAP1 POLR1F AP1G2 GNAI2 PLEC DNAJC13 WASHC4 EP400 RASA2 DSP KIF21A SAE1 RICTOR MSH6 PPP2R1A GTF3C1 FHOD1 LAS1L | 1.23e-05 | 1353 | 200 | 22 | 29467282 |
| Pubmed | 1.53e-05 | 9 | 200 | 3 | 15500642 | ||
| Pubmed | 1.53e-05 | 9 | 200 | 3 | 23263282 | ||
| Pubmed | 1.68e-05 | 27 | 200 | 4 | 11156964 | ||
| Pubmed | 1.96e-05 | 57 | 200 | 5 | 31862882 | ||
| Pubmed | 2.28e-05 | 98 | 200 | 6 | 26561776 | ||
| Pubmed | 2.42e-05 | 147 | 200 | 7 | 16959763 | ||
| Pubmed | ATP6V1B2 PDE1B MYO5A DBN1 SYNGAP1 ATP6V1D PLEC CAP2 AKAP5 SRCIN1 PPP2R1A | 2.43e-05 | 403 | 200 | 11 | 30562941 | |
| Pubmed | ERCC4 RNF168 MYO5A USP9X PTPN2 USP32 PLEC HERC1 RNF213 TEFM GTF2E1 PRKCI | 2.51e-05 | 481 | 200 | 12 | 28190767 | |
| Pubmed | TPR EED RNF168 IQGAP1 POLR1F PTPN2 PLEC CUL4B EP400 NUP98 SAE1 RNF213 MSH6 PPP2R1A GTF2E1 MTA1 GTF3C1 MYO15A | 2.56e-05 | 1014 | 200 | 18 | 32416067 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 2.99e-05 | 11 | 200 | 3 | 20427287 | |
| Pubmed | TPR ATP6V1B2 EED MYO5A DBN1 F2 IQGAP1 POLR1F TXNDC5 GNAI2 KIF5C PLEC NUP98 LRRFIP1 | 3.18e-05 | 660 | 200 | 14 | 32780723 | |
| Pubmed | KNTC1 KAZN MAML3 SIN3B RAP1GAP SYNM CEP290 ANKRD26 RNF213 RICTOR PPP4R4 DNAH17 | 3.18e-05 | 493 | 200 | 12 | 15368895 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 11792814 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 2159327 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 34921012 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 17662978 | ||
| Pubmed | SPARC Interacts with Actin in Skeletal Muscle in Vitro and in Vivo. | 3.29e-05 | 2 | 200 | 2 | 27908613 | |
| Pubmed | Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis. | 3.29e-05 | 2 | 200 | 2 | 34815391 | |
| Pubmed | The nucleoporin Nup98 associates with the intranuclear filamentous protein network of TPR. | 3.29e-05 | 2 | 200 | 2 | 11248057 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 35926563 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 25788576 | ||
| Pubmed | IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. | 3.29e-05 | 2 | 200 | 2 | 20977743 | |
| Pubmed | Thrombin-Induced Microglia Activation Modulated through Aryl Hydrocarbon Receptors. | 3.29e-05 | 2 | 200 | 2 | 37511175 | |
| Pubmed | Isolation and differential tissue distribution of two human cDNAs encoding PDE1 splice variants. | 3.29e-05 | 2 | 200 | 2 | 11747989 | |
| Pubmed | Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. | 3.29e-05 | 2 | 200 | 2 | 18180285 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 3.29e-05 | 2 | 200 | 2 | 24718612 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 24586179 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 26800321 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 17761684 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 31578382 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 24011658 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 28215293 | ||
| Pubmed | Post-transcriptional regulation of ITGB6 protein levels in damaged skeletal muscle. | 3.29e-05 | 2 | 200 | 2 | 24488487 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 15337775 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 3.29e-05 | 2 | 200 | 2 | 24931616 | |
| Pubmed | Keratin K6irs is specific to the inner root sheath of hair follicles in mice and humans. | 3.29e-05 | 2 | 200 | 2 | 11703281 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 12943661 | ||
| Pubmed | Mannan-Binding Lectin Suppresses Peptidoglycan-Induced TLR2 Activation and Inflammatory Responses. | 3.29e-05 | 2 | 200 | 2 | 30728747 | |
| Pubmed | FHOD1 interaction with nesprin-2G mediates TAN line formation and nuclear movement. | 3.29e-05 | 2 | 200 | 2 | 24880667 | |
| Pubmed | Stage and cell-specific expression of calmodulin-dependent phosphodiesterases in mouse testis. | 3.29e-05 | 2 | 200 | 2 | 11369604 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 37694145 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 18950740 | ||
| Pubmed | MTA1 promotes viability and motility in nasopharyngeal carcinoma by modulating IQGAP1 expression. | 3.29e-05 | 2 | 200 | 2 | 29125886 | |
| Pubmed | TIPE2 gene transfer with adeno-associated virus 9 ameliorates dystrophic pathology in mdx mice. | 3.29e-05 | 2 | 200 | 2 | 30608588 | |
| Pubmed | In vivo proximity biotin ligation identifies the interactome of Egalitarian, a Dynein cargo adaptor. | 3.29e-05 | 2 | 200 | 2 | 35020877 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 22768332 | ||
| Pubmed | Infrequent mutations of the PPP2R1A and PPP2R1B genes in patients with ovarian cancer. | 3.29e-05 | 2 | 200 | 2 | 23588898 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 24998570 | ||
| Interaction | KRT19 interactions | KRT72 EED BICD1 ODF2L KRT71 KRT77 USP32 PLEC DMD KRT1 KRT3 DSP SYNM CEP290 ANKRD26 ID1 SAE1 | 2.54e-09 | 282 | 196 | 17 | int:KRT19 |
| Interaction | KRT8 interactions | KRT72 MYH1 EED USP9X LRRC49 KRT71 KRT77 USP32 PLEC DMD BICD2 KRT1 KRT3 DSP SYNM KRT35 ANKRD26 RICTOR PPL | 6.71e-08 | 441 | 196 | 19 | int:KRT8 |
| Interaction | PRPH interactions | KRT72 MYO5A BICD1 KRT71 KRT77 PLEC CUL4B BICD2 KRT1 KRT3 DSP SYNM CEP41 | 1.06e-07 | 204 | 196 | 13 | int:PRPH |
| Interaction | KRT18 interactions | KRT72 KNTC1 EED LRRC49 MCC ODF2L KRT71 KRT77 USP32 PLEC BICD2 KRT1 KRT3 DSP CEP290 ANKRD26 PPP2R1A | 7.83e-07 | 419 | 196 | 17 | int:KRT18 |
| Interaction | KRT25 interactions | 1.01e-06 | 35 | 196 | 6 | int:KRT25 | |
| Interaction | AGAP2 interactions | IQGAP2 MYO5A USP9X MCC DBN1 IQGAP1 SYNGAP1 PIP5KL1 LRRC7 SYNE1 SRCIN1 PPP2R1A | 1.06e-06 | 210 | 196 | 12 | int:AGAP2 |
| Interaction | RGS14 interactions | MYO5A DBN1 SYNGAP1 LRRC7 GNAI2 CUL4B MICAL1 SRCIN1 TG PPP2R1A ELMO2 LRRFIP1 | 4.27e-06 | 240 | 196 | 12 | int:RGS14 |
| Interaction | SUMO2 interactions | TPR ERCC4 RNF168 USP9X RRM1 IQGAP1 PLEC HSF2 EP400 SAE1 RNF213 XPNPEP1 MSH6 PPP2R1A MTA1 BRF1 GTF3C1 TTI1 LAS1L | 5.42e-06 | 591 | 196 | 19 | int:SUMO2 |
| Interaction | LRRC31 interactions | KNTC1 MYO5A IQGAP1 PLEC KRT1 DNAJC13 DSP RICTOR FRYL NBAS MSH6 | 5.53e-06 | 205 | 196 | 11 | int:LRRC31 |
| Interaction | DSCAM interactions | ATP6V1B2 IQGAP1 BICD1 SYNGAP1 PLEC CAP2 WASHC4 SYNE1 KIF21A ENC1 | 6.99e-06 | 171 | 196 | 10 | int:DSCAM |
| Interaction | MINDY4 interactions | 7.00e-06 | 73 | 196 | 7 | int:MINDY4 | |
| Interaction | AHI1 interactions | 1.64e-05 | 83 | 196 | 7 | int:AHI1 | |
| Interaction | KRT5 interactions | 2.01e-05 | 193 | 196 | 10 | int:KRT5 | |
| Interaction | TMOD3 interactions | TPR ATP6V1B2 EED MYO5A DBN1 IQGAP1 PTPN2 TXNDC5 RICTOR TBCK LRRFIP1 | 2.72e-05 | 243 | 196 | 11 | int:TMOD3 |
| Interaction | USP7 interactions | TPR EED RNF168 MYO5A USP9X STYXL2 DBN1 IQGAP1 ATP6V1D PLEC DMD HERC1 CUL4B KRT1 ANK1 DSP SYNE1 FAT3 NUP98 ID1 PPL ZBBX PPP2R1A SLC9A2 TLR2 MMRN2 PRKCI LAS1L PLEKHO1 | 2.89e-05 | 1313 | 196 | 29 | int:USP7 |
| Interaction | RYR1 interactions | 5.90e-05 | 43 | 196 | 5 | int:RYR1 | |
| Interaction | USP53 interactions | 6.26e-05 | 138 | 196 | 8 | int:USP53 | |
| Interaction | CEP135 interactions | LRRC49 BICD1 ODF2L CEP120 ATP6V1D BICD2 SYNM CEP290 ANKRD26 ELMO2 PRKCI | 7.56e-05 | 272 | 196 | 11 | int:CEP135 |
| Interaction | PCM1 interactions | EED RNF168 USP9X LRRC49 BICD1 ODF2L CEP120 CC2D2A BICD2 KRT1 DSP CEP290 ANKRD26 PRKCI | 9.40e-05 | 434 | 196 | 14 | int:PCM1 |
| Interaction | FBXO32 interactions | MYH1 MYH8 RTN2 TELO2 USP32 PLEC CUL4B BICD2 KRT1 DSP NUP98 GTF3C1 LAS1L | 1.09e-04 | 386 | 196 | 13 | int:FBXO32 |
| Interaction | NPHP4 interactions | 1.10e-04 | 236 | 196 | 10 | int:NPHP4 | |
| Interaction | KRT84 interactions | 1.11e-04 | 49 | 196 | 5 | int:KRT84 | |
| Interaction | VIM interactions | KRT72 EED IQGAP1 BICD1 SYNGAP1 KRT77 AHR PLEC CUL4B BICD2 KRT1 KRT3 MICAL1 DSP SYNM RICTOR PPL TFE3 MTA1 CEP41 | 1.17e-04 | 804 | 196 | 20 | int:VIM |
| Interaction | LUZP1 interactions | 1.23e-04 | 194 | 196 | 9 | int:LUZP1 | |
| Interaction | WDR5B interactions | 1.23e-04 | 50 | 196 | 5 | int:WDR5B | |
| Interaction | KRT16 interactions | 1.38e-04 | 197 | 196 | 9 | int:KRT16 | |
| Interaction | PPP1R9B interactions | ATP6V1B2 EED PDE1B MYO5A DBN1 IQGAP1 SYNGAP1 ATP6V1D LRRC7 PLEC CAP2 AKAP5 DSP SRCIN1 PPP2R1A BRF1 TBCK | 1.39e-04 | 626 | 196 | 17 | int:PPP1R9B |
| Interaction | EED interactions | KNTC1 TPR EED USP9X NDST4 DBN1 RRM1 IQGAP1 TXNDC5 GNAI2 ADAM17 PLEC CUL4B KRT1 EPS8L2 WASHC4 EP400 DSP CEP290 NUP98 RICTOR XPNPEP1 MSH6 PPP2R1A MTA1 GTF3C1 GET3 LAS1L TGS1 | 1.57e-04 | 1445 | 196 | 29 | int:EED |
| Interaction | KRT27 interactions | 1.66e-04 | 202 | 196 | 9 | int:KRT27 | |
| Interaction | KRT24 interactions | 1.78e-04 | 54 | 196 | 5 | int:KRT24 | |
| Interaction | SUPT5H interactions | ATP6V1B2 EED DBN1 SYNE2 MAML3 CAP2 EP400 CEP290 MSH6 PPP2R1A PPP2R1B GTF3C1 PLEKHO1 | 1.89e-04 | 408 | 196 | 13 | int:SUPT5H |
| Interaction | MYCBP2 interactions | TPR EED PDE1B DBN1 IQGAP1 SYNGAP1 SYNE2 CUL4B TXNIP PPP2R1A GUCY1B1 LRRFIP1 | 1.95e-04 | 355 | 196 | 12 | int:MYCBP2 |
| Interaction | KRT28 interactions | 1.95e-04 | 30 | 196 | 4 | int:KRT28 | |
| Cytoband | 12q13.13 | 1.16e-05 | 67 | 200 | 5 | 12q13.13 | |
| Cytoband | 15q26.1 | 9.32e-05 | 54 | 200 | 4 | 15q26.1 | |
| GeneFamily | Keratins, type II | 1.52e-06 | 27 | 135 | 5 | 609 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.22e-05 | 8 | 135 | 3 | 939 | |
| GeneFamily | Phosphodiesterases | 2.81e-05 | 24 | 135 | 4 | 681 | |
| GeneFamily | Protein phosphatase 2 scaffold subunits|STRIPAK complex | 5.53e-05 | 2 | 135 | 2 | 1266 | |
| GeneFamily | TTT complex | 1.65e-04 | 3 | 135 | 2 | 1320 | |
| GeneFamily | Myosin heavy chains | 1.73e-04 | 15 | 135 | 3 | 1098 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.29e-04 | 4 | 135 | 2 | 1252 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 8.30e-04 | 25 | 135 | 3 | 775 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 8.30e-04 | 25 | 135 | 3 | 565 | |
| GeneFamily | Guanylate cyclase receptors | 1.13e-03 | 7 | 135 | 2 | 343 | |
| GeneFamily | SPARC family | 1.50e-03 | 8 | 135 | 2 | 1278 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 2.39e-03 | 10 | 135 | 2 | 830 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP9X MELK BICD1 PTPN2 SYNE2 ADAM17 KAZN KIF5C DMD CAP2 DNAJC13 WASHC4 ENC1 NUP98 ID1 FRYL PAIP1 NBAS MSH6 PRKCI LRRFIP1 | 2.52e-06 | 856 | 199 | 21 | M4500 |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | TSNAXIP1 IQGAP2 RGS22 LRRC49 CHST6 ODF2L ATP6V1D SYNE2 CC2D2A GNAI2 DMD ENOSF1 DNAH3 NWD1 DSP SYNE1 KIF21A CEP290 ANKRD26 DNTTIP1 ZBBX RSPH3 CEP41 CFAP53 | 3.18e-06 | 1093 | 199 | 24 | M41649 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | DBN1 AP1G2 GNAI2 ADAM17 PLEC EP400 SYNM NUP98 TXNIP MSH6 MYOM2 | 9.25e-06 | 276 | 199 | 11 | M3063 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 2.30e-05 | 250 | 199 | 10 | M11318 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN | 2.36e-05 | 200 | 199 | 9 | M5153 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | PDE3B RNF168 PTPN2 ODF2L SYNE2 ADAM17 KIF5C MAML3 KIF21A GTF2E1 GTF3C1 TTI1 | 4.31e-07 | 203 | 196 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPR PDE3B EED RNF168 PDE1B MYO5A USP9X LRRC49 RRM1 TTF1 BICD1 POLR1F ODF2L CEP120 FBXO5 FAM83F SYNE2 DMD HSF2 CUL4B TICRR KIF21A CEP290 ANKRD26 MSH6 PAXIP1 TTI1 PLEKHO1 TGS1 | 4.80e-06 | 1257 | 196 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.52e-06 | 30 | 196 | 5 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | RNF168 PEX12 TTC1 BICD1 ODF2L SYNE2 USP32 KIF5C HSF2 MAML3 CUL4B KIF21A ENC1 LYSMD3 PAIP1 GTF3C1 CEP41 TTI1 | 1.10e-05 | 595 | 196 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | PDE1A RNF168 PEX12 TTC1 PTPN2 ODF2L SYNE2 KIF5C DMD HSF2 MAML3 KIF21A CEP290 GTF2E1 RSPH3 GTF3C1 CEP41 TTI1 | 2.30e-05 | 629 | 196 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | DENND2A PDE1A NUP62CL MCC IMPACT SYNGAP1 SYNE2 HSF2 MYRF SHISA6 CAP2 CUL4B TICRR TNC FAT3 RNF213 PPP4R4 GUCY1B1 CEP41 PLEKHO1 TGS1 | 2.78e-05 | 827 | 196 | 21 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RNF168 MYO5A USP9X SYNGAP1 ODF2L SYNE2 CC2D2A KIF5C DMD ANKRD40 CAP2 ST7 FAT3 KIF21A CEP290 ANKRD26 GRIK4 RNF14 CGRRF1 TTI1 TGS1 | 2.99e-05 | 831 | 196 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPR PDE3B EED RNF168 PDE1B MYO5A USP9X LRRC49 RRM1 TTF1 BICD1 POLR1F ODF2L CEP120 FBXO5 FAM83F SYNE2 KIF5C DMD HSF2 CUL4B TICRR KIF21A CEP290 ANKRD26 MSH6 PAXIP1 TTI1 PLEKHO1 TGS1 | 2.99e-05 | 1459 | 196 | 30 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | KNTC1 TPR DENND2A PDE1C MYO5A MELK BICD1 ODF2L FBXO5 SYNE2 USP32 KIF5C DMD HSF2 MYRF CUL4B TICRR FAT3 KIF21A CEP290 ENC1 ANKRD26 FRYL ZNF710 DGKK TTI1 PLEKHO1 TGS1 | 6.31e-05 | 1370 | 196 | 28 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 PDE1C RGS22 DMD ANK1 FAT3 GUCY2F DGKK MYH15 MYOM2 MYO15A | 7.86e-10 | 184 | 200 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 PDE1C RGS22 DMD ANK1 FAT3 GUCY2F DGKK MYH15 MYOM2 MYO15A | 7.86e-10 | 184 | 200 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 PDE1C RGS22 DMD ANK1 FAT3 GUCY2F DGKK MYH15 MYOM2 MYO15A | 7.86e-10 | 184 | 200 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TSNAXIP1 RGS22 ODF2L SYNE2 DMD DNAH3 SYNE1 CEP290 ANKRD26 SRCIN1 ZBBX | 1.62e-09 | 197 | 200 | 11 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.36e-08 | 198 | 200 | 10 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.60e-08 | 200 | 200 | 10 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-07 | 183 | 200 | 9 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-07 | 184 | 200 | 9 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-07 | 186 | 200 | 9 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-07 | 186 | 200 | 9 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 188 | 200 | 9 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 188 | 200 | 9 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-07 | 191 | 200 | 9 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 192 | 200 | 9 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 192 | 200 | 9 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-07 | 193 | 200 | 9 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-07 | 193 | 200 | 9 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-07 | 194 | 200 | 9 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-07 | 197 | 200 | 9 | bbb7c106d5b96b8e95aeb3e5c293e104fceea234 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-07 | 197 | 200 | 9 | b0fb5774525ba05f60c635d42f14bb8d79bff17c | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.94e-07 | 198 | 200 | 9 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.94e-07 | 198 | 200 | 9 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.07e-07 | 199 | 200 | 9 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.20e-07 | 200 | 200 | 9 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.20e-07 | 200 | 200 | 9 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.14e-06 | 172 | 200 | 8 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.42e-06 | 177 | 200 | 8 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-06 | 177 | 200 | 8 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 181 | 200 | 8 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 181 | 200 | 8 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-06 | 182 | 200 | 8 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-06 | 182 | 200 | 8 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-06 | 186 | 200 | 8 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.06e-06 | 186 | 200 | 8 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-06 | 187 | 200 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 187 | 200 | 8 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 187 | 200 | 8 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 187 | 200 | 8 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 188 | 200 | 8 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-06 | 188 | 200 | 8 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.23e-06 | 188 | 200 | 8 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 188 | 200 | 8 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 188 | 200 | 8 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 189 | 200 | 8 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 189 | 200 | 8 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 189 | 200 | 8 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 189 | 200 | 8 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 2.41e-06 | 190 | 200 | 8 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 191 | 200 | 8 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | COVID-19_Mild-MAIT|COVID-19_Mild / Disease condition and Cell class | 2.51e-06 | 191 | 200 | 8 | e834d7a6aa7bb4f194b203d351e53bf5d95175d6 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 191 | 200 | 8 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.60e-06 | 192 | 200 | 8 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.60e-06 | 192 | 200 | 8 | e4dd24aefdf13cd4206714f02fde2288f3173ffc | |
| ToppCell | PND03-Epithelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.60e-06 | 192 | 200 | 8 | d8c23693f690d4d568585537bbfedda05d505b3d | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.81e-06 | 194 | 200 | 8 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.81e-06 | 194 | 200 | 8 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.92e-06 | 195 | 200 | 8 | 43164511f32e4591cb5399182fbac0b911716233 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.92e-06 | 195 | 200 | 8 | 9337111d75a487abc02969337718c30b1fe81379 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 196 | 200 | 8 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 196 | 200 | 8 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 196 | 200 | 8 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.03e-06 | 196 | 200 | 8 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.03e-06 | 196 | 200 | 8 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 197 | 200 | 8 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.27e-06 | 198 | 200 | 8 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.27e-06 | 198 | 200 | 8 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 198 | 200 | 8 | 53e9ed1b19cb26be58da0f37057caca0cdfaabeb | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 198 | 200 | 8 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.27e-06 | 198 | 200 | 8 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class | 3.27e-06 | 198 | 200 | 8 | 6aea5d00c417708f05b6d2dfe5a962d80864f8eb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.27e-06 | 198 | 200 | 8 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.40e-06 | 199 | 200 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.40e-06 | 199 | 200 | 8 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 3.52e-06 | 200 | 200 | 8 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-06 | 200 | 200 | 8 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.52e-06 | 200 | 200 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.52e-06 | 200 | 200 | 8 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.05e-06 | 153 | 200 | 7 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.78e-06 | 159 | 200 | 7 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-05 | 167 | 200 | 7 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-05 | 174 | 200 | 7 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.41e-05 | 116 | 200 | 6 | 9c92e714e210a2f29a9e228653d4c990ec643c72 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.47e-05 | 69 | 200 | 5 | 0862e6c8d8af4310b9a1f0879e51ee25115b26b1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.47e-05 | 69 | 200 | 5 | d2ff9cea216122d697822cdd2eecbce8f557728d | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-05 | 176 | 200 | 7 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-05 | 177 | 200 | 7 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 179 | 200 | 7 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 179 | 200 | 7 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-05 | 179 | 200 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.68e-05 | 179 | 200 | 7 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-05 | 181 | 200 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.81e-05 | 181 | 200 | 7 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 1.94e-05 | 183 | 200 | 7 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-05 | 184 | 200 | 7 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-05 | 184 | 200 | 7 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-05 | 184 | 200 | 7 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.01e-05 | 184 | 200 | 7 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-05 | 184 | 200 | 7 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-05 | 184 | 200 | 7 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-05 | 185 | 200 | 7 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| Computational | Neighborhood of REV3L | 5.51e-06 | 58 | 129 | 7 | MORF_REV3L | |
| Drug | Ro 15-2041 | 8.23e-08 | 26 | 199 | 6 | CID000132434 | |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | PDE3B RRM1 LYST IQGAP1 PLEC HSF2 BICD2 NEMP1 TXNIP LMAN1 ELMO2 | 7.00e-07 | 184 | 199 | 11 | 1344_DN |
| Drug | AC1L73CW | 7.31e-07 | 84 | 199 | 8 | CID000328776 | |
| Drug | N-ethyl-N-nitrosourea | EED ERCC4 PDE1B GCK F2 LYST KRT71 FES HERC1 SYNM MSH6 TLR2 PAXIP1 | 9.83e-07 | 275 | 199 | 13 | CID000012967 |
| Drug | Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | PDE3B NUP62CL DBN1 MAPK8IP3 FGFR2 KIF5C MICAL1 CEP290 ANKRD26 NBAS ARFRP1 | 1.37e-06 | 197 | 199 | 11 | 7230_DN |
| Drug | sildenafil | 2.03e-06 | 96 | 199 | 8 | CID000005212 | |
| Drug | desethyl KBT-3022 | 2.75e-06 | 26 | 199 | 5 | CID000127736 | |
| Drug | adenosine 3',5'-cyclic phosphate | KRT72 PDE1A PDE1C PDE3B PDE1B SPOCK1 GCK KRT71 KRT77 SCNN1A GNAI2 DMD CAP2 KRT1 KRT3 NPR1 AKAP5 SYNM KRT35 TG GUCY1B1 GUCY2F PRKCI | 4.84e-06 | 907 | 199 | 23 | CID000000274 |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 6.43e-06 | 188 | 199 | 10 | 4545_DN | |
| Drug | Benzbromarone [3562-84-3]; Up 200; 9.4uM; HL60; HT_HG-U133A | TSNAXIP1 PDE3B LYST POLR1F ADAM17 HSF2 CUL4B NEMP1 WASHC4 LMAN1 | 6.74e-06 | 189 | 199 | 10 | 1291_UP |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; PC3; HT_HG-U133A | TSNAXIP1 RTN2 MAPK8IP3 PTPN2 KAZN AKAP5 CEP290 GUCY1B1 TLR2 PLEKHO1 | 7.39e-06 | 191 | 199 | 10 | 1240_UP |
| Drug | plakin | 7.66e-06 | 82 | 199 | 7 | CID000018752 | |
| Drug | imidazole-4-carboxamide | 8.06e-06 | 32 | 199 | 5 | CID000152917 | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A | DENND2A PTPN2 MYRF MICAL1 DNAH3 RAP1GAP SYNE1 MTA1 MYH15 PLEKHO1 | 8.10e-06 | 193 | 199 | 10 | 4488_DN |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 8.10e-06 | 193 | 199 | 10 | 2079_UP | |
| Drug | AC1L9LMC | 8.30e-06 | 83 | 199 | 7 | CID000448113 | |
| Drug | PDEs | 8.39e-06 | 116 | 199 | 8 | CID003036959 | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | IQGAP1 FGFR2 BICD2 RASA2 ENC1 ZNF710 TXNIP ARFRP1 BRF1 LMAN1 | 8.87e-06 | 195 | 199 | 10 | 3835_DN |
| Drug | Napelline [5008-52-6]; Down 200; 11.2uM; HL60; HT_HG-U133A | PDE3B LYST CAP2 NUP98 RNF14 PPP2R1B MTA1 ARFRP1 LMAN1 DCAF11 | 9.70e-06 | 197 | 199 | 10 | 2522_DN |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 9.70e-06 | 197 | 199 | 10 | 3411_DN | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; PC3; HT_HG-U133A | MAPK8IP3 BICD1 FGFR2 MYRF DNAH3 CEP290 GALNT12 PPP2R1B GUCY1B1 MYH15 | 9.70e-06 | 197 | 199 | 10 | 6694_DN |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; HL60; HT_HG-U133A | DBN1 ADAM17 HSF2 NEMP1 RNF14 PPP2R1B ARFRP1 LMAN1 ELMO2 DCAF11 | 9.70e-06 | 197 | 199 | 10 | 1311_DN |
| Drug | 1-2q | KRT72 GCK KRT77 PLEC KRT1 KRT3 DSP KRT35 KIF21A CEP290 TFE3 MSH6 | 9.72e-06 | 289 | 199 | 12 | CID000011820 |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | TSNAXIP1 MAPK8IP3 PTPN2 CUL4B CEP290 ANKRD26 ID1 TXNIP ARFRP1 DCAF11 | 1.01e-05 | 198 | 199 | 10 | 6925_UP |
| Drug | GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A | DENND2A PDE1C PLEC NEMP1 MICAL1 TNC ARFRP1 LMAN1 ELMO2 DCAF11 | 1.01e-05 | 198 | 199 | 10 | 7048_DN |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; PC3; HT_HG-U133A | DENND2A IMPACT PLXND1 ST7 ANKRD26 MTA1 LMAN1 ELMO2 PLEKHO1 TGS1 | 1.06e-05 | 199 | 199 | 10 | 4068_DN |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; PC3; HT_HG-U133A | DENND2A ERCC4 MAPK8IP3 MYRF TNC CEP290 ANKRD26 GUCY1B1 DNAH17 TGS1 | 1.11e-05 | 200 | 199 | 10 | 6628_DN |
| Drug | EHNA | 1.13e-05 | 87 | 199 | 7 | CID000003206 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | KNTC1 MYH1 PDE1A PDE1C PDE3B EED PDE1B F2 DMD TNFAIP8L2 NPR1 MMEL1 GUCY1B1 GUCY2F FHOD1 CORIN PRKCI | 1.37e-05 | 577 | 199 | 17 | CID000000295 |
| Drug | rolipram | PDE1A PDE1C PDE3B PDE1B AHR ENOSF1 TNFAIP8L2 NPR1 GRIK4 GUCY1B1 GUCY2F | 1.50e-05 | 253 | 199 | 11 | CID000005092 |
| Drug | pyridinone | 1.57e-05 | 18 | 199 | 4 | CID000065002 | |
| Drug | AH 21-132 | 1.68e-05 | 37 | 199 | 5 | CID003035793 | |
| Drug | YC-1 compound | 2.81e-05 | 41 | 199 | 5 | CID000005712 | |
| Drug | AA-2379 | 3.02e-05 | 21 | 199 | 4 | CID000128390 | |
| Drug | orthovanadate | ATP6V1B2 PDE1A PDE1C PDE3B PDE1B GCK PTPN2 ATP6V1D DNAH3 TNC GET3 DNAH17 PRKCI ACP4 | 3.11e-05 | 435 | 199 | 14 | CID000061672 |
| Drug | AC1L1X4J | 3.57e-05 | 8 | 199 | 3 | CID000011330 | |
| Drug | HWA 153 | 3.66e-05 | 22 | 199 | 4 | CID000162797 | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 4.13e-05 | 187 | 199 | 9 | 1656_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 4.30e-05 | 188 | 199 | 9 | 6735_DN | |
| Drug | lomustine; Down 200; 100uM; PC3; HT_HG-U133A | 4.30e-05 | 188 | 199 | 9 | 7050_DN | |
| Drug | griseolic acid | 4.40e-05 | 23 | 199 | 4 | CID000127607 | |
| Drug | atherosperminine | 4.40e-05 | 23 | 199 | 4 | CID000096918 | |
| Drug | Speract | 5.25e-05 | 24 | 199 | 4 | CID000123688 | |
| Drug | STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A | 5.28e-05 | 193 | 199 | 9 | 6869_DN | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.28e-05 | 193 | 199 | 9 | 6587_UP | |
| Drug | PF-04254644 | 5.31e-05 | 9 | 199 | 3 | ctd:C551178 | |
| Drug | milrinone | 5.39e-05 | 150 | 199 | 8 | CID000004197 | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 5.72e-05 | 195 | 199 | 9 | 6918_UP | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; HL60; HT_HG-U133A | 5.72e-05 | 195 | 199 | 9 | 1318_UP | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; HL60; HG-U133A | 5.72e-05 | 195 | 199 | 9 | 1984_DN | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; PC3; HT_HG-U133A | 5.95e-05 | 196 | 199 | 9 | 5749_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; PC3; HG-U133A | 5.95e-05 | 196 | 199 | 9 | 1904_UP | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; HL60; HG-U133A | 5.95e-05 | 196 | 199 | 9 | 1624_DN | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 6607_DN | |
| Drug | sodium 4-phenylbutyrate; Up 200; 1000uM; MCF7; HG-U133A | LRRC49 MAPK8IP3 FBXO5 ANKRD26 TXNIP PPP2R1B SIDT2 TTI1 PLEKHO1 | 6.19e-05 | 197 | 199 | 9 | 407_UP |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 4266_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 6.43e-05 | 198 | 199 | 9 | 7384_DN | |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; PC3; HT_HG-U133A | 6.43e-05 | 198 | 199 | 9 | 7294_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | PLXND1 RTN2 MAPK8IP3 MICAL1 DNAH3 PPP4R4 ZNF710 ARFRP1 MMRN2 | 6.43e-05 | 198 | 199 | 9 | 5703_DN |
| Drug | Chlorpropamide [94-20-2]; Up 200; 14.4uM; HL60; HG-U133A | 6.43e-05 | 198 | 199 | 9 | 1594_UP | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | 6.43e-05 | 198 | 199 | 9 | 4551_DN | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; PC3; HT_HG-U133A | 6.43e-05 | 198 | 199 | 9 | 4074_DN | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 6.69e-05 | 199 | 199 | 9 | 7355_DN | |
| Drug | NSC611747 | MYH1 PDE1C MYH8 PDE3B MYO5A TRPC4 DBN1 F2 PPP2R1A PPP2R1B PRKCI MYO15A | 6.70e-05 | 352 | 199 | 12 | CID000002534 |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.95e-05 | 200 | 199 | 9 | 4789_DN | |
| Drug | T-440 | 7.28e-05 | 26 | 199 | 4 | CID000177965 | |
| Drug | forskolin from Coleus forskohlii | MYH1 PDE1A PDE1C PDE3B PDE1B GCK F2 SCNN1A AHR FGFR2 TNFAIP8L2 NPR1 RAP1GAP AKAP5 TFE3 TG SLC9A2 MTA1 GUCY1B1 GUCY2F PRKCI ACP4 | 8.19e-05 | 1013 | 199 | 22 | CID000003413 |
| Drug | IBMX | PDE1A PDE1C PDE3B PDE1B F2 GNAI2 KRT1 TNFAIP8L2 NPR1 GUCY1B1 GUCY2F PRKCI | 1.02e-04 | 368 | 199 | 12 | CID000003758 |
| Drug | teleocidin B | 1.06e-04 | 123 | 199 | 7 | CID000072425 | |
| Drug | cilostazol | 1.09e-04 | 86 | 199 | 6 | CID000002754 | |
| Drug | P-NE | 1.24e-04 | 169 | 199 | 8 | CID000446755 | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.35e-04 | 171 | 199 | 8 | 991_UP | |
| Drug | homocysteine thiolactone | 1.57e-04 | 131 | 199 | 7 | CID000107712 | |
| Drug | 9-beta-D-arabinofuranosylguanine | PDE1A PDE1C PDE3B PDE1B IQGAP2 ARL11 TTC1 IQGAP1 GNAI2 NPR1 RASA2 TNC GALNT12 PPL MMEL1 GUCY1B1 GUCY2F PRKCI TGS1 | 1.60e-04 | 843 | 199 | 19 | CID000000765 |
| Drug | AC1MBZ1C | PDE1C PDE3B PDE1B SCNN1A PLEC HSF2 NPR1 RAP1GAP AKAP5 SLC9A2 PRKCI ACP4 | 1.63e-04 | 387 | 199 | 12 | CID000003541 |
| Drug | OPC 3911 | 1.76e-04 | 13 | 199 | 3 | CID000131164 | |
| Drug | dyphylline | 1.90e-04 | 33 | 199 | 4 | CID000003182 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 2.15e-04 | 183 | 199 | 8 | 7550_UP | |
| Drug | U46619 | 2.16e-04 | 285 | 199 | 10 | CID000005618 | |
| Drug | Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 184 | 199 | 8 | 3244_UP | |
| Drug | NP-EGTA | 2.23e-04 | 14 | 199 | 3 | CID000183793 | |
| Drug | 2-pyrrolidinethione | 2.27e-04 | 3 | 199 | 2 | CID002775267 | |
| Drug | trimecaine | 2.27e-04 | 3 | 199 | 2 | CID000012028 | |
| Drug | x C2 | 2.27e-04 | 3 | 199 | 2 | CID011705720 | |
| Drug | m-benzenediacetic acid | 2.27e-04 | 3 | 199 | 2 | CID000029788 | |
| Drug | strontium chromate | 2.36e-04 | 99 | 199 | 6 | CID000024599 | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.40e-04 | 186 | 199 | 8 | 5010_DN | |
| Drug | zaprinast | 2.47e-04 | 141 | 199 | 7 | CID000005722 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; HL60; HT_HG-U133A | 2.77e-04 | 190 | 199 | 8 | 1343_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 2.77e-04 | 190 | 199 | 8 | 4307_DN | |
| Drug | TG-1 | 2.77e-04 | 15 | 199 | 3 | CID000060499 | |
| Drug | isoproterenol | MYH1 PDE1A PDE1C MYH8 PDE3B PDE1B MYO5A F2 SCNN1A GNAI2 DMD NPR1 GUCY1B1 GUCY2F PRKCI MYO15A | 2.78e-04 | 669 | 199 | 16 | CID000003779 |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.87e-04 | 191 | 199 | 8 | 4269_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.87e-04 | 191 | 199 | 8 | 1057_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A_EA | 2.87e-04 | 191 | 199 | 8 | 994_UP | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; HL60; HT_HG-U133A | 2.87e-04 | 191 | 199 | 8 | 6142_DN | |
| Drug | Paclitaxel [33069-62-4]; Down 200; 4.6uM; PC3; HT_HG-U133A | 2.87e-04 | 191 | 199 | 8 | 6720_DN | |
| Drug | 17-AAG; Down 200; 1uM; ssMCF7; HG-U133A | 2.87e-04 | 191 | 199 | 8 | 521_DN | |
| Drug | AC1L9MJT | 2.97e-04 | 192 | 199 | 8 | CID000448959 | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.97e-04 | 192 | 199 | 8 | 7427_DN | |
| Disease | Malignant neoplasm of breast | MYH1 TRPC4 DBN1 FAM83F SYNE2 AHR EXOC3L1 LRRC7 GNAI2 FGFR2 DMD MICAL1 RAP1GAP ANK1 SYNE1 NUP98 MSH6 SLC9A2 ARFRP1 GUCY2F LRRFIP1 | 1.14e-05 | 1074 | 197 | 21 | C0006142 |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 3.40e-05 | 10 | 197 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 3.40e-05 | 10 | 197 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 3.40e-05 | 10 | 197 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 3.40e-05 | 10 | 197 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 3.40e-05 | 10 | 197 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 3.40e-05 | 10 | 197 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 3.40e-05 | 10 | 197 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 3.40e-05 | 10 | 197 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | spinal muscular atrophy with lower extremity predominant 2A (implicated_via_orthology) | 4.43e-05 | 2 | 197 | 2 | DOID:0070349 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 6.17e-05 | 12 | 197 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 6.17e-05 | 12 | 197 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 7.98e-05 | 13 | 197 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.26e-04 | 15 | 197 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Striate palmoplantar keratoderma | 1.32e-04 | 3 | 197 | 2 | C4707237 | |
| Disease | Polydactyly | 1.39e-04 | 117 | 197 | 6 | C0152427 | |
| Disease | Rheumatoid Arthritis | 1.76e-04 | 174 | 197 | 7 | C0003873 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.02e-04 | 80 | 197 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.64e-04 | 4 | 197 | 2 | cv:CN293514 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 2.64e-04 | 4 | 197 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | SPARC MCC IPP DMD DNAH3 SYNE1 GALNT12 MSH6 TNNI3K PPP2R1B BRF1 TLR2 MMRN2 LAS1L | 2.85e-04 | 702 | 197 | 14 | C0009402 |
| Disease | Familial aplasia of the vermis | 3.07e-04 | 20 | 197 | 3 | cv:C0431399 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 4.38e-04 | 5 | 197 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 4.38e-04 | 5 | 197 | 2 | C0410190 | |
| Disease | Joubert syndrome with ocular defect | 4.38e-04 | 5 | 197 | 2 | C4274118 | |
| Disease | Amelogenesis imperfecta type 1 | 4.38e-04 | 5 | 197 | 2 | cv:C0399367 | |
| Disease | Emery-Dreifuss muscular dystrophy | 6.54e-04 | 6 | 197 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 6.54e-04 | 6 | 197 | 2 | C0410189 | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 9.11e-04 | 7 | 197 | 2 | C0399367 | |
| Disease | Arima syndrome | 9.11e-04 | 7 | 197 | 2 | C1855675 | |
| Disease | glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement | 9.11e-04 | 7 | 197 | 2 | EFO_0800551 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 9.11e-04 | 7 | 197 | 2 | C0751337 | |
| Disease | hypertension | 1.12e-03 | 307 | 197 | 8 | EFO_0000537 | |
| Disease | conduct disorder | 1.15e-03 | 31 | 197 | 3 | EFO_0004216 | |
| Disease | primary pulmonary hypertension (is_marker_for) | 1.21e-03 | 8 | 197 | 2 | DOID:14557 (is_marker_for) | |
| Disease | Developmental Coordination Disorder | 1.21e-03 | 8 | 197 | 2 | C0011757 | |
| Disease | Motor Skills Disorders | 1.21e-03 | 8 | 197 | 2 | C0026613 | |
| Disease | Squamous cell carcinoma of lung | 1.26e-03 | 32 | 197 | 3 | C0149782 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.32e-03 | 71 | 197 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Distal arthrogryposis | 1.55e-03 | 9 | 197 | 2 | cv:C0265213 | |
| Disease | Thyroid Gland Follicular Adenoma | 1.64e-03 | 35 | 197 | 3 | C0151468 | |
| Disease | lip morphology measurement | 1.75e-03 | 189 | 197 | 6 | EFO_0007845 | |
| Disease | Meckel-Gruber syndrome | 1.93e-03 | 10 | 197 | 2 | cv:C0265215 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.93e-03 | 37 | 197 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Thyroid Neoplasm | 1.93e-03 | 37 | 197 | 3 | C0040136 | |
| Disease | mean arterial pressure | PDE1A POLR1F METTL21A FES ENOSF1 NPR1 RNF213 PPL TFE3 GUCY1B1 | 2.03e-03 | 499 | 197 | 10 | EFO_0006340 |
| Disease | Cardiomegaly | 2.25e-03 | 82 | 197 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 2.25e-03 | 82 | 197 | 4 | C1383860 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.69e-03 | 206 | 197 | 6 | C0152013 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.80e-03 | 12 | 197 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Sclerocystic Ovaries | 2.87e-03 | 144 | 197 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 2.87e-03 | 144 | 197 | 5 | C0032460 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 2.97e-03 | 43 | 197 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | hemorrhoid | 3.13e-03 | 147 | 197 | 5 | EFO_0009552 | |
| Disease | high grade glioma (implicated_via_orthology) | 3.17e-03 | 44 | 197 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Thyroid carcinoma | 3.17e-03 | 44 | 197 | 3 | C0549473 | |
| Disease | Intellectual Disability | 3.26e-03 | 447 | 197 | 9 | C3714756 | |
| Disease | Tobacco Dependence | 3.83e-03 | 14 | 197 | 2 | C0040332 | |
| Disease | Nicotine Dependence | 3.83e-03 | 14 | 197 | 2 | C0028043 | |
| Disease | Nicotine Use Disorder | 3.83e-03 | 14 | 197 | 2 | C0376384 | |
| Disease | Adenocarcinoma of large intestine | 3.97e-03 | 96 | 197 | 4 | C1319315 | |
| Disease | unipolar depression, bipolar disorder | 4.04e-03 | 156 | 197 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | myopathy (implicated_via_orthology) | 4.06e-03 | 48 | 197 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | glycerophospholipid measurement | 4.31e-03 | 49 | 197 | 3 | EFO_0007630 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.31e-03 | 49 | 197 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Meckel-Gruber syndrome | 4.40e-03 | 15 | 197 | 2 | C0265215 | |
| Disease | Germ Cell Cancer | 4.40e-03 | 15 | 197 | 2 | C0740345 | |
| Disease | level of C-X-C motif chemokine 3 in blood serum | 4.40e-03 | 15 | 197 | 2 | OBA_2041208 | |
| Disease | Embryonal Neoplasm | 4.40e-03 | 15 | 197 | 2 | C0027654 | |
| Disease | Neoplasms, Germ Cell and Embryonal | 4.40e-03 | 15 | 197 | 2 | C0027658 | |
| Disease | Germ cell tumor | 4.40e-03 | 15 | 197 | 2 | C0205851 | |
| Disease | Neoplasms, Embryonal and Mixed | 4.40e-03 | 15 | 197 | 2 | C0205852 | |
| Disease | Cancer, Embryonal | 4.40e-03 | 15 | 197 | 2 | C0751364 | |
| Disease | Cancer, Embryonal and Mixed | 4.40e-03 | 15 | 197 | 2 | C0751365 | |
| Disease | obsolete aging, cognition | 4.40e-03 | 15 | 197 | 2 | EFO_0003925, GO_0007568 | |
| Disease | asthma, chronic obstructive pulmonary disease | 4.56e-03 | 50 | 197 | 3 | EFO_0000341, MONDO_0004979 | |
| Disease | corpus callosum volume measurement | 4.59e-03 | 100 | 197 | 4 | EFO_0010299 | |
| Disease | platelet component distribution width | DENND2A EED IQGAP2 DAPK2 SH2D4B PLEC HERC1 SYNE1 ZNF710 SIDT2 BRF1 TGS1 | 5.00e-03 | 755 | 197 | 12 | EFO_0007984 |
| Disease | Pre-Eclampsia | 5.00e-03 | 16 | 197 | 2 | C0032914 | |
| Disease | ankle brachial index | 5.00e-03 | 16 | 197 | 2 | EFO_0003912 | |
| Disease | Liver Cirrhosis | 5.09e-03 | 103 | 197 | 4 | C0023890 | |
| Disease | Disease Exacerbation | 5.11e-03 | 165 | 197 | 5 | C0235874 | |
| Disease | Fibrosis, Liver | 5.45e-03 | 105 | 197 | 4 | C0239946 | |
| Disease | Alzheimer disease | 5.52e-03 | 485 | 197 | 9 | MONDO_0004975 | |
| Disease | allergic rhinitis (is_marker_for) | 5.65e-03 | 17 | 197 | 2 | DOID:4481 (is_marker_for) | |
| Disease | erythritol measurement | 5.65e-03 | 17 | 197 | 2 | EFO_0021171 | |
| Disease | methylcobalamin deficiency type cblE, overall survival, ovarian carcinoma, response to cisplatin | 5.65e-03 | 17 | 197 | 2 | EFO_0000638, EFO_0001075, GO_0072718, MONDO_0009354 | |
| Disease | Amelogenesis imperfecta | 5.65e-03 | 17 | 197 | 2 | cv:C0002452 | |
| Disease | Peripheral Nervous System Diseases | 5.66e-03 | 54 | 197 | 3 | C4721453 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 5.66e-03 | 54 | 197 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | Necrosis | 5.96e-03 | 55 | 197 | 3 | C0027540 | |
| Disease | Dupuytren Contracture | 6.02e-03 | 108 | 197 | 4 | EFO_0004229 | |
| Disease | Liver Cirrhosis, Experimental | SPARC MYO5A ARL11 GCK ITGB6 IQGAP1 ATP6V1D GNAI2 ADAM17 BICD2 ENC1 LRRFIP1 | 6.05e-03 | 774 | 197 | 12 | C0023893 |
| Disease | Meckel syndrome type 1 | 6.32e-03 | 18 | 197 | 2 | C3714506 | |
| Disease | Adrenocortical carcinoma | 6.32e-03 | 18 | 197 | 2 | C0206686 | |
| Disease | Malignant neoplasm of endometrium | 6.32e-03 | 18 | 197 | 2 | C0007103 | |
| Disease | Hypertrophy | 6.32e-03 | 18 | 197 | 2 | C0020564 | |
| Disease | Carcinoma in situ of endometrium | 6.32e-03 | 18 | 197 | 2 | C0346191 | |
| Disease | Ciliopathies | 6.42e-03 | 110 | 197 | 4 | C4277690 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSLIERLYEINVEDT | 766 | Q15361 | |
| TDTIYDEDEVLLALA | 56 | P30153 | |
| IYDEDEVLLALAEQL | 71 | P30154 | |
| DFRDIDLTDEILTYV | 571 | P35869 | |
| EAYVSLRELEQLRED | 161 | Q86VI1 | |
| LRLEQEEAELLTYTR | 2211 | Q96L91 | |
| RLLQDYSELEEENIS | 176 | Q8TD16 | |
| ARLLQDYTELEEENI | 166 | Q96G01 | |
| TYTDDRALLEDQLFI | 91 | Q9UKJ8 | |
| EIDLEADTVLATLYA | 201 | Q96KE9 | |
| VRLLLQYDAEIDDIT | 321 | P16157 | |
| LDVELQQRAVEYDTL | 556 | O75843 | |
| IIILYDDDERLASQA | 221 | Q9BYV8 | |
| DFIEIELDRQELTYQ | 276 | Q6AI12 | |
| EAVRLLVSVDEADYE | 291 | Q8WXF8 | |
| ESEVNLDRYQTALEE | 336 | P11532 | |
| NLEELVEERTQAYLE | 826 | P16066 | |
| SLEVTSRYRINLEDE | 1241 | Q9UPS8 | |
| TISRNVALVYELLDE | 101 | O00189 | |
| ERERDVYEELLTQAE | 281 | P46940 | |
| VLSLDDEVLQDVYRD | 601 | Q149M9 | |
| EYTALARQLEAALEE | 571 | Q9ULJ1 | |
| IDIDEDRETERIYSL | 751 | Q15283 | |
| YADQSLNTERDLEII | 311 | Q8IZ41 | |
| LNTERDLEIIRAYTE | 316 | Q8IZ41 | |
| DLEIIRAYTEDRNSL | 321 | Q8IZ41 | |
| ILRSEELSIEDEYQV | 186 | Q9Y573 | |
| ASLVDIEEAQRSYIL | 71 | P17706 | |
| LDEFLLEYDRLVDES | 266 | P35557 | |
| SEDYRQLELVILQSE | 56 | Q9NPC2 | |
| DYIISQDRLSEEETR | 96 | Q14680 | |
| TDILVYVLDSTDEAR | 81 | Q969Q4 | |
| DEQNYILRDAEAEVL | 941 | Q6ZW49 | |
| DLDRILTLTTNEEYL | 756 | P21802 | |
| YDRLSVLIDVLAEEA | 711 | Q5KSL6 | |
| YIRDLQLELNSESEV | 101 | P41134 | |
| ESKSLEELRLEDYQA | 196 | P52948 | |
| SSQLELEEAFRLYEL | 81 | P41743 | |
| ELDTTFLRELNVLDY | 266 | Q5T9C9 | |
| QLYATLESREEQLRD | 161 | Q674X7 | |
| DILEEDAEVYELRSR | 31 | Q7Z3D4 | |
| ELLREDNEQLLTQYE | 81 | Q9UPT6 | |
| EQLELERRDTVSLYQ | 101 | Q96JK9 | |
| RTLEELYLDANQIEE | 46 | Q96NW7 | |
| DYVLDLVSDLELLRD | 2281 | Q9UKN7 | |
| TTARREEELQYTLED | 386 | Q9H8L6 | |
| DALIDEIDFLRTLYD | 326 | P12035 | |
| EIDFLRTLYDAELSQ | 331 | P12035 | |
| DLDSIIAEVRAQYED | 366 | P12035 | |
| EDLEEVDLLYVQTLN | 4616 | Q15751 | |
| YQEDRNDLVISETEL | 336 | P40123 | |
| DFRYITDVLTEEDAL | 151 | Q7L5Y1 | |
| YEESLDQLETLRREN | 1491 | P13535 | |
| QSYILRDLDDTSVVE | 1616 | Q9Y4D7 | |
| LQLIISAYEELRSEV | 361 | P18564 | |
| SAYEELRSEVELEVL | 366 | P18564 | |
| DLEIATYRTLLEGEE | 476 | P04264 | |
| EEQLRSYQSELEALR | 1206 | O60437 | |
| VYIDETRRLLDTEDE | 66 | P54750 | |
| LLEAVYIDETRQILD | 66 | Q01064 | |
| YIDETRQILDTEDEL | 71 | Q01064 | |
| YIDETRRLLDTEDEL | 76 | Q14123 | |
| EVSLDLILVEEYDSL | 656 | Q13370 | |
| LLTEEEYRIQGEVET | 341 | O14524 | |
| EDEDVDLAQVLAYLL | 36 | Q8TEB1 | |
| LEYVDLTRQLLEAEN | 1016 | O94915 | |
| RIIDESYNLTELDTI | 191 | Q86YV6 | |
| LISLDLYDNQIEEIS | 136 | Q8IUZ0 | |
| LDEQRRYVSSLTEEI | 356 | P49257 | |
| ELLVSYEEEQFTVLE | 271 | Q9Y4W2 | |
| QEEELLLLYIEDLLN | 751 | P50748 | |
| EVLAERESLYQLLSQ | 431 | Q8TDZ2 | |
| LSLELYRNTITDEEL | 156 | H0YM25 | |
| EIRLLQSYVDADADE | 131 | O75530 | |
| EEYKLTQELEILTDR | 361 | Q02153 | |
| YETEVSLRQLVESDI | 186 | Q92764 | |
| AYEESLDQLETLKRE | 1491 | P12882 | |
| LELLAAYEEVIREES | 11 | Q16643 | |
| LTLSLDRYILVDIDD | 296 | Q9H3R1 | |
| YSIFDVLRDELEVIL | 136 | Q495T6 | |
| ELLETARYQEEAERE | 671 | Q8NDA8 | |
| LADIRENEQSLLEYL | 941 | P52701 | |
| ERADLSNSLEEIYIQ | 81 | Q9P2X3 | |
| EGEEETILYDLLVNT | 16 | A2RRP1 | |
| QRKIESEEYEEALSL | 531 | A2RRP1 | |
| DLIEEQLNEALTTYR | 841 | Q6R327 | |
| LRLLDIESQEELEDF | 101 | Q9H6S3 | |
| VTTDDALQELVELIY | 191 | Q9H074 | |
| IYLEETFTDLLQTLE | 146 | Q8WXB1 | |
| LREATEAAEYQEALE | 166 | Q9BZG2 | |
| DYEQEAELRLTLTAV | 201 | Q9Y5E9 | |
| VDASSEYQQELEREL | 61 | P18859 | |
| LRELLALEENEYFTE | 101 | Q96M91 | |
| VIYVIDSTDEERLAE | 96 | Q13795 | |
| IEAYELLLALAESEQ | 456 | P23508 | |
| DTLTSRRLISEEEYE | 31 | Q9BX69 | |
| RRLISEEEYETLENV | 36 | Q9BX69 | |
| EAYEAEIQAEISELL | 546 | Q9P2K1 | |
| DTSQYNLEIRELERL | 241 | Q8NA47 | |
| DVRLEYLEEVASIVL | 6 | Q9UFH2 | |
| YSSLLDEIRAVEEEE | 1921 | Q8TD57 | |
| TRTLSEENVYEDILD | 361 | Q9ULE3 | |
| DTYIRIVLENSSRED | 386 | Q96JJ3 | |
| EYERTISSLEEEIVQ | 1381 | O15078 | |
| VLEEGLDDYLTRLIE | 936 | Q8N960 | |
| LDDYLTRLIEERDTL | 941 | Q8N960 | |
| DVYENRTDVVLILEL | 91 | Q9UIK4 | |
| NEIEALETSRLYEDS | 131 | Q9UKT4 | |
| ELNEKITRLTYEIED | 1106 | P15924 | |
| YSSNLEDLIRERTEE | 831 | P51841 | |
| EQELYELVVEASREL | 2046 | Q8TDW7 | |
| ILLEEVILVDDYSDR | 166 | Q8IXK2 | |
| EDRTSEQYETLLIET | 381 | P24588 | |
| TIIEEYEDEISSLIA | 51 | Q3B7I2 | |
| RAVVDYDISIVELSE | 886 | Q9Y5Q5 | |
| YLRLLLEEDENEESG | 831 | O75165 | |
| ADYVSETLDLNDLLI | 3171 | Q99698 | |
| EFLSLYETERLIQEL | 251 | O43681 | |
| VLQTSLEEVELLYEF | 46 | Q6UWF9 | |
| ELETEDERLVYESAI | 201 | O14682 | |
| YLDTELSLEEQREML | 81 | Q9Y613 | |
| VDIFELLRDSEYETA | 66 | Q16099 | |
| LLTLADEDDREIYDI | 176 | Q99675 | |
| ELEELDRITEQTLFD | 146 | P37088 | |
| LEEEADRLITYLDQT | 421 | Q13620 | |
| VADLTLNLDDYIDAE | 101 | Q92530 | |
| ELEEQLAESRRQYEE | 201 | Q32MZ4 | |
| RISDDIIIYDVTDDN | 241 | Q03933 | |
| ILQEYLEISSLVQDE | 226 | P07332 | |
| YLDVDLTLTREQTER | 416 | O75298 | |
| LRETEDVNLAYEILE | 191 | P29083 | |
| EEALTSDDLLYLEFL | 441 | P21281 | |
| QDDELIRYISELAIT | 1961 | Q93008 | |
| TLDDDLDTVQRDKIY | 816 | Q8NBJ9 | |
| NYVIDEQEESLRELE | 81 | A8MYB1 | |
| EDLSDIERAVYLLSA | 51 | Q6NUP7 | |
| YISADDISILNERVE | 7741 | Q8NF91 | |
| RYQTLLRQLSEIEEE | 2021 | Q8WXH0 | |
| RETVQLYEDEVRELE | 196 | O15061 | |
| ISSLYRQLDDKDDEI | 421 | O60282 | |
| EDLFDTAEEYILLLL | 756 | Q8NE09 | |
| ERDAYEELLTQAEIQ | 281 | Q13576 | |
| EELLEATERINLFYT | 1716 | Q9Y2K3 | |
| VALSAYDLVLAEDEE | 226 | P04899 | |
| EERTRAALLETLYEE | 386 | P47736 | |
| TLRAVEADEELTVAY | 321 | Q8WTS6 | |
| YEDRQILEDAAALIS | 656 | O75182 | |
| YDRILSDEQLLSTER | 386 | Q6ZSJ9 | |
| FQYEEDELSLELLAL | 426 | Q9Y4R8 | |
| TYEEDSELLLQIRND | 261 | Q9UBE0 | |
| STELQRVEELYDSLL | 331 | Q96QE5 | |
| LNETESLKSYLERED | 131 | Q13330 | |
| AYILLAEEEATTIAE | 241 | Q9NRC1 | |
| EKLVSSLREEDEYSI | 131 | O00623 | |
| NRILDEVTVEEDSYL | 136 | Q53GL0 | |
| TEFRELYAISEEVDL | 286 | Q8NEG4 | |
| TTTNYLIELIDRVDD | 246 | P78536 | |
| VYSEDEQRNLALDLV | 361 | Q9GZX3 | |
| ESREYSLEEVKELLN | 1576 | Q63HN8 | |
| REAQEDELLALASIY | 6 | Q9UBS8 | |
| QTELYLEEIADRIIE | 256 | Q86UC2 | |
| IDETSSEVLDELYRV | 31 | Q6P589 | |
| EDSAYLAEFLEEILR | 761 | Q7Z2Z1 | |
| ETNRTLSLDEVYLID | 401 | Q9NQW7 | |
| IDDVIDEIISLESSY | 261 | P19532 | |
| EEERLRYLNDEELIT | 716 | Q9C0H9 | |
| LEEYERRLLSQEEQT | 1216 | Q96PV0 | |
| SETDEIRELLSRNLY | 596 | Q9UBY0 | |
| AYLLIEEDIRDLAAS | 266 | Q9H147 | |
| EDIDAAIETYNLLSE | 181 | P23921 | |
| DLIRTNERLSQELEY | 126 | P12270 | |
| NERLSQELEYLTEDV | 131 | P12270 | |
| LYNEEVLDLFDTTRD | 151 | Q7Z4S6 | |
| VTLYERDEDNNLLTE | 176 | P09486 | |
| ESAEQLLVEDLYNRV | 86 | Q5VZP5 | |
| ERTLAYIITELDERE | 181 | Q9Y5K8 | |
| EIIDSNRLLETVEYN | 1471 | P24821 | |
| DITGLREATEYEIEL | 1676 | P24821 | |
| SVVLLDDLEYERELG | 391 | Q08629 | |
| TAEAAALERELLEDY | 71 | A6XGL0 | |
| LDRLDINVQIDDSYL | 271 | Q8N1W2 | |
| IREQLDAELLRYSES | 71 | Q3B726 | |
| AEDLFEARIISLETY | 3786 | Q15149 | |
| DINNDYLAERSIEEV | 311 | Q8TEA7 | |
| ASEEYIQRLLAEEEE | 141 | Q8IYW5 | |
| ELDLSGIDDLEIDRY | 446 | Q92994 | |
| GIDDLEIDRYILNES | 451 | Q92994 | |
| EEYTSQLRRIEDALD | 36 | Q2M389 | |
| SLEDKTERELLESYI | 346 | P00734 | |
| RDLESLREYVESQLQ | 281 | Q8NBS9 | |
| YEEISEELIAERARL | 91 | Q5SQS7 | |
| LEYERQLVLELLDTD | 16 | Q92889 | |
| ELETENYERDSLLAT | 581 | Q96RS0 | |
| LQDRYEEIDLETGIL | 71 | Q12789 | |
| LQEQLDTLRASYEEV | 271 | Q2TAA8 | |
| TSEYLRYEDTLLLED | 66 | Q9H3M7 | |
| DVNSSELDEEYLIEL | 86 | Q99614 | |
| SESYVITIERLEDDL | 21 | Q59H18 | |
| LEELEIDASDLQSYE | 176 | O60603 | |
| AETGLELLLDEIYDT | 246 | P01266 | |
| LSYEEALRRVTDVEL | 11 | Q8NFA0 | |
| EIILNYRDDNSLIEE | 266 | Q9UBN4 | |
| IEYIDITDQNELSLD | 676 | A8MT70 | |
| EELREIVTSILEEYT | 551 | O43156 | |
| LDSIIDAVRTQYELI | 331 | Q7Z794 | |
| DLDSIIDEVRTQYEE | 296 | Q3SY84 | |
| DLDSIIAEVRAQYEE | 291 | Q14CN4 | |
| EELLAREQLEYTIEE | 1551 | Q8IZF0 | |
| LEYESLKRQELESEN | 1201 | Q9Y4I1 | |
| ELEFLLTYLEESTRD | 146 | Q9H1M0 | |
| DDVLYETETLPNLER | 1166 | P54296 | |
| LYVLSLRTEEDLVDT | 786 | Q9Y2G1 |